Page last updated: 2024-10-23

aspirin and Angor Pectoris

aspirin has been researched along with Angor Pectoris in 320 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"To investigate the effects of supplementing qi and activating blood circulation method (YQHX) on platelet aggregation rate (PAgR), platelet adhesion rate (PAdR) and thromboxane B2(TXB2) level in patients with stable angina pectoris and intolerable to aspirin."9.13[Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin]. ( Chen, KY; Gao, L; Li, YJ, 2008)
"Aspirin resistance may increase the risk of major adverse cardiac events (MACE) more than threefold in patients with stable coronary artery disease (CAD)."9.12Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). ( Mercanoglu, F; Meric, M; Nisanci, Y; Oflaz, H; Oncul, A; Onur, I; Ozcan, M; Pamukcu, B; Umman, B, 2007)
"Clinical trials have demonstrated a prophylactic role for aspirin in myocardial infarction and in unstable angina pectoris."9.07Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. ( Edvardsson, N; Jahnmatz, B; Juul-Möller, S; Omblus, R; Rosén, A; Sørensen, S, 1992)
"The objective of this study was to examine the effect of low-dose aspirin (325 mg on alternate days) on the primary prevention of angina pectoris in the United States Physicians' Health Study."9.06Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. ( Buring, JE; Gaziano, JM; Goldhaber, SZ; Grobbee, DE; Hennekens, CH; Manson, JE; Ridker, PM; Stampfer, MJ; Taylor, JO, 1990)
" Although a 150 mg dose of aspirin reduced urinary dinor-TxB2 levels by over 75 per cent, it had no effect on the course of the chronic recurrent form of angina pectoris due to vasospasm ("vasotonic angina")."9.05Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. ( FitzGerald, GA; Friesinger, GC; Maas, RL; Oates, JA; Roberts, LJ; Robertson, D; Robertson, RM, 1981)
" This study was designed to determine the relation between responses to aspirin and clopidogrel as assessed by a point-of-care assay (Verify Now, Accumetrics, San Diego, California) and periprocedural myocardial infarction (PMI) in patients undergoing elective PCI for stable angina."7.74Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. ( Barbato, E; Bartunek, J; Cuisset, T; De Bruyne, B; Hamilos, M; Sarma, J; Sarno, G; Vanderheyden, M; Wijns, W; Wyffels, E, 2008)
" A patient suffering from coronary artery disease and taking metoprolol and aspirin was stung by wasps and developed cutaneous allergic signs including rash, urticaria and orbital oedema."7.74Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration. ( Ioannidis, TI; Karpeta, MZ; Kounis, GN; Kounis, NG; Mazarakis, A; Notaras, SP; Rallis, DG; Tsintoni, AC, 2007)
" All suffered stent thrombosis after discontinuation (in three cases prematurely) of clopidogrel therapy."7.73[Thrombosis of a coronary stent after discontinuing treatment with clopidogrel]. ( de Boer, MJ; Hautvast, RW; Heestermans, AA; Jaarsma, W; ten Berg, JM; van Werkum, JW, 2006)
"Between September 1999 and April 2002, a total of 1,236 patients hospitalized for acute coronary syndrome (ACS) were questioned in order to determine whether aspirin intake had been interrupted."7.73Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. ( Benhamou, M; Cerboni, P; Ferrari, E; Marcel, B, 2005)
"Between 1950 and 1975, 473 Rochester patients had the diagnosis of rheumatoid arthritis and received aspirin treatment."7.66Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. ( Fuster, V; Kurland, LT; Linos, A; O'Fallon, W; Whisnant, JP; Worthington, JW, 1978)
"When ticlopidine was given for 72 hours, TF levels were similar to normal laboratory values both in stable and unstable patients."6.69Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris. ( Ariëns, RA; Bernies, M; Bossi, IM; Brambilla, GM; Donatelli, F; Fajadet, J; Gregorini, L; Marco, I; Marco, J; Mari, D; Romano, SM; Somalvico, F, 2000)
" On the basis of present information it is evident that, in addition to heparin, all patients suffering from suspected acute myocardial infarction should receive immediate low dose aspirin which should be continued for one to six months."6.16Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategies. ( McGregor, M; Silberberg, JS, 1989)
" Conditions characterized by a reduction in platelet survival and where dipyridamole has been used include heart valve replacement, arterial grafting, cerebrovascular disorders, and disorders of peripheral circulation."6.15Dipyridamole: a critical evaluation. ( Alexander, MR; Rivey, MP; Taylor, JW, 1984)
"Aspirin was given as 160 mg/day and clopidogrel as 300 mg loading dose followed by 75 mg/day."5.35Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris. ( Agewall, S; Berglund, M; Gordon, A; Saha, S; Sylvén, C, 2008)
"Definite/probable ST and MB (TIMI major and Bleeding Academic Research Consortium (BARC) ≥ 3) were compared in 2 subsequent trials with similar inclusion criteria but different DAPT duration, that is, BASKET (6 months; n = 557) and BASKET-PROVE (12 months; n = 2,314), between months 0 to 6 (DAPT in both trials), 7 to 12 (DAPT in BASKET-PROVE only), and 13 to 24 (aspirin in both trials) using propensity score-adjusted, time-stratified Cox proportional hazard models."5.19Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. ( Alber, H; Bonetti, PO; Eberli, F; Erne, P; Galatius, S; Jeger, RV; Kaiser, CA; Pedrazzini, G; Pfisterer, ME; Rickli, H; Sørensen, R; von Felten, S, 2014)
"We assessed in a prospective and randomized study the benefit of higher dose of aspirin, in association with clopidogrel, on aspirin response and non COX-specific platelet testing in patients receiving Drug Eluting Stent (DES) for stable angina pectoris."5.14Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study. ( Bali, L; Bonnet, JL; Cuisset, T; Frere, C; Gaborit, B; Lambert, M; Morange, PE; Moro, PJ; Mouret, JP; Quilici, J; Uhry, S, 2009)
"To investigate the effects of supplementing qi and activating blood circulation method (YQHX) on platelet aggregation rate (PAgR), platelet adhesion rate (PAdR) and thromboxane B2(TXB2) level in patients with stable angina pectoris and intolerable to aspirin."5.13[Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin]. ( Chen, KY; Gao, L; Li, YJ, 2008)
"Aspirin resistance may increase the risk of major adverse cardiac events (MACE) more than threefold in patients with stable coronary artery disease (CAD)."5.12Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR). ( Mercanoglu, F; Meric, M; Nisanci, Y; Oflaz, H; Oncul, A; Onur, I; Ozcan, M; Pamukcu, B; Umman, B, 2007)
" Thirty-nine patients with angina pectoris who were scheduled for coronary stent implantation were assigned to either group 1 (160 mg aspirin + 500 mg ticlopidine post-stent), group 2 (160 mg aspirin + abciximab + 500 mg ticlopidine post-stent) or group 3 (160 mg aspirin + loading dose (375/450 mg) clopidogrel pre-stent and 75 mg clopidogrel post-stent)."5.10Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention. ( Bosmans, JM; Claeys, MJ; Dilling, D; Michiels, JJ; Van Der Planken, MG; Vertessen, F; Vrints, CJ, 2002)
"5 and 75 mg of aspirin per day each reduced the incidence of coronary heart disease (CHD)."5.10Antithrombotic treatment and the incidence of angina pectoris. ( Brennan, PJ; Knottenbelt, C; Meade, TW, 2002)
"The second European Stroke Prevention Study investigated the prevention of stroke and/or death in 6602 patients with transient ischaemic attack or stroke with aspirin (25 mg b."5.09Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). ( Bertrand-Hardy, JM; Darius, H; Diener, HC; Humphreys, M, 2001)
"Clinical trials have demonstrated a prophylactic role for aspirin in myocardial infarction and in unstable angina pectoris."5.07Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. ( Edvardsson, N; Jahnmatz, B; Juul-Möller, S; Omblus, R; Rosén, A; Sørensen, S, 1992)
"Our data indicated that alternate-day aspirin therapy greatly reduced the risk for first myocardial infarction among patients with chronic stable angina, a group of patients at high risk for cardiovascular death (P less than 0."5.07Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. ( Buring, JE; Gaziano, JM; Hennekens, CH; Manson, JE; Ridker, PM, 1991)
"The objective of this study was to examine the effect of low-dose aspirin (325 mg on alternate days) on the primary prevention of angina pectoris in the United States Physicians' Health Study."5.06Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. ( Buring, JE; Gaziano, JM; Goldhaber, SZ; Grobbee, DE; Hennekens, CH; Manson, JE; Ridker, PM; Stampfer, MJ; Taylor, JO, 1990)
"We tested the usefulness of aspirin (325 mg twice daily), heparin (1000 units per hour by intravenous infusion), and a combination of the two in the early management of acute unstable angina pectoris in a double-blind, randomized, placebo-controlled trial involving 479 patients."5.06Aspirin, heparin, or both to treat acute unstable angina. ( deGuise, P; Joly, P; Juneau, M; Latour, JG; Lévy, G; McCans, J; Ouimet, H; Pelletier, E; Stasiak, J; Théroux, P, 1988)
" Although a 150 mg dose of aspirin reduced urinary dinor-TxB2 levels by over 75 per cent, it had no effect on the course of the chronic recurrent form of angina pectoris due to vasospasm ("vasotonic angina")."5.05Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. ( FitzGerald, GA; Friesinger, GC; Maas, RL; Oates, JA; Roberts, LJ; Robertson, D; Robertson, RM, 1981)
"A randomized, double-blind clinical trial in 1266 men with unstable angina showed that 324 mg of aspirin daily for 12 weeks reduced the incidence of myocardial infarction by 51% (p = ."5.05Unstable angina: status of aspirin and other forms of therapy. ( Lewis, HD, 1985)
" Meta-analyses revealed that aspirin in combination with FDD was significantly more effective at alleviating angina pectoris and improving electrocardiogram (ECG) results relative to aspirin therapy alone, reflected by the summary effects for the clinical markedly effective (OR = 2."4.93Clinical Therapeutic Effects of Aspirin in Combination with Fufang Danshen Diwan, a Traditional Chinese Medicine Formula, on Coronary Heart Disease: A Systematic Review and Meta-Analysis. ( He, J; Huang, J; Kong, X; Tang, X; Ye, F, 2016)
"Using the key terms acute coronary syndrome, atherothrombosis, ischemic stroke, myocardial infarction, MI, peripheral arterial disease, TIA, transient ischemic attack, unstable angina,aspirin,ticlopidine,dipyridamole, and clopidogrel, we searched the MEDLINE database as well as the trial register of the Cochrane Groups to identify studies published from 1960 to August 2004."4.82Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. ( Anand, SS; Tran, H, 2004)
" In elective de novo lesions has shown remarkably clear lumens at follow-up angiography and intravascular ultrasound within the stented segments were observed with no lesion progression at the stent margins or thrombosis after a 2 month regimen of aspirin, and ticlopodine or clopidogrel."4.81Sirolimus-eluting stents: a review of experimental and clinical findings. ( Albiero, R; Colombo, A; Corvaja, N; Di Mario, C; Falotico, R; Stankovic, G; Takagi, T; Toutouzas, K, 2002)
" Strategies used for plaque stabilisation resulting in a reduction in cardiovascular mortality and morbidity are: smoking cessation; aspirin (acetylsalicylic acid); blood pressure control; lipid lowering agents when low density lipoprotein cholesterol is elevated despite dietary therapy; coronary bypass surgery in patients with left main stem disease or triple vessel coronary disease and diminished left ventricular function; and use of estrogen in postmenopausal women."4.80Choosing the most appropriate treatment for stable angina. Safety considerations. ( Asirvatham, S; Sebastian, C; Thadani, U, 1998)
"Aspirin showed significant benefits when administered in patients with acute myocardial infarction or unstable angina, and also when used for secondary prevention in patients with known coronary artery disease."4.80[Aspirin and prevention of cardiovascular risk]. ( Gabriel Steg, P; Karila-Cohen, D, 2000)
"The primary drugs utilized in the treatment of angina pectoris include organic nitrates, beta-adrenoceptor antagonists, Ca2+ antagonists, and the antithrombotic agents aspirin and heparin."4.79Pharmacologic therapy of angina pectoris. ( Bueno, O; Zavecz, JH, 1995)
" For primary prevention, aspirin showed no effect in a British study, but reduced the incidence of myocardial infarction by 44% per year in an American trial concerning men and by 32% concerning women."4.79[Blood thinning in heart patients]. ( Meier, B, 1995)
" These studies, in conjunction with recent histopathologic studies demonstrating plaque defects and overlying thrombosis in patients with unstable ischemia and sudden death, suggest a common mechanism for unstable angina and myocardial infarction and strongly support the rationale for antithrombotic therapy with heparin and with aspirin in the management of patients with unstable angina."4.77Thrombosis in unstable angina: angiographic aspects. ( Cowley, MJ; DiSciascio, G; Rehr, RB, 1987)
"Eighty-two consecutive patients with stable angina pectoris who received Resolute zotarolimus-eluting stents (R-ZESs; Medtronic Cardiovascular, Santa Rosa, CA, USA) were enrolled."3.88Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy. ( Fujimoto, W; Kawai, H; Miyata, T; Oishi, S; Onishi, T; Osue, T; Sawada, T; Shimane, A; Takahashi, Y; Takaya, T; Taniguchi, Y; Toba, T; Yasaka, Y, 2018)
"In patients with coronary artery disease (CAD), though aspirin inhibits platelet activation and reduces atherothrombotic complications, it does not always sufficiently inhibit platelet function, thereby causing a clinical situation known as aspirin resistance."3.83Does high serum uric acid level cause aspirin resistance? ( Alihanoglu, YI; Bilgin, M; Ergin, A; Esin, F; Evrengul, H; Kaftan, HA; Kilic, ID; Ozkan, E; Ozkan, H; Yildiz, BS, 2016)
"The authors studied efficacy of the generic clopidogrel Еgithromb manufactured by EGIS PHARMACEUTICALS (Hungary) based on clinical data and parameters of light aggregometry in a total of 30 patients subjected to planned subcutaneous coronary intervention for stable angina pectoris."3.79[Assessment of clinical and antiaggregation efficacy of generic clopidogrel 'Egithromb' in roentgenosurgical practice]. ( Faĭl', IL; Loenko, VB; Smialovskiĭ, DV; Sorokina, EA, 2013)
" A patient suffering from coronary artery disease and taking metoprolol and aspirin was stung by wasps and developed cutaneous allergic signs including rash, urticaria and orbital oedema."3.74Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration. ( Ioannidis, TI; Karpeta, MZ; Kounis, GN; Kounis, NG; Mazarakis, A; Notaras, SP; Rallis, DG; Tsintoni, AC, 2007)
" This study was designed to determine the relation between responses to aspirin and clopidogrel as assessed by a point-of-care assay (Verify Now, Accumetrics, San Diego, California) and periprocedural myocardial infarction (PMI) in patients undergoing elective PCI for stable angina."3.74Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. ( Barbato, E; Bartunek, J; Cuisset, T; De Bruyne, B; Hamilos, M; Sarma, J; Sarno, G; Vanderheyden, M; Wijns, W; Wyffels, E, 2008)
" All suffered stent thrombosis after discontinuation (in three cases prematurely) of clopidogrel therapy."3.73[Thrombosis of a coronary stent after discontinuing treatment with clopidogrel]. ( de Boer, MJ; Hautvast, RW; Heestermans, AA; Jaarsma, W; ten Berg, JM; van Werkum, JW, 2006)
"Between September 1999 and April 2002, a total of 1,236 patients hospitalized for acute coronary syndrome (ACS) were questioned in order to determine whether aspirin intake had been interrupted."3.73Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. ( Benhamou, M; Cerboni, P; Ferrari, E; Marcel, B, 2005)
"The in vitro effect of acetylsalicylic acid (ASA) on fibrin gel lysis by exogenous t-PA was studied in 13 patients with angina pectoris."3.69The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator. ( Blombäck, M; Fatah, K; Ivert, T; Williams, S, 1995)
" There were 12 independent significant predictors for readmission: clinical history (a previous history of either congestive heart failure or myocardial infarction, or CABG); acute operation; postoperative complications (time in intensive care unit greater than two days, neurological complications); clinical findings four to seven days after the operation (arrhythmia, systolic murmur equivalent to mitral regurgitation); medication four to seven days after the operation (antidiabetics, diuretics for heart failure, other antiarrhythmics (other than beta blockers, calcium antagonists, and digitalis), and lack of treatment with aspirin)."3.69Predictors of hospital readmission two years after coronary artery bypass grafting. ( Albertsson, P; Brandrup-Wognsen, G; Emanuelsson, H; Haglid, M; Hartford, M; Herlitz, J; Hjalmarson, A; Karlson, BW; Karlsson, T; Sandén, W, 1997)
"N-Acetylcysteine (N-AC) potentiates the systemic and coronary hemodynamic and antianginal effects of nitroglycerin (NGT) in humans; NTG/N-AC reduces the incidence of acute myocardial infarction in patients with unstable angina pectoris."3.69N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation. ( Chirkov, YY; Horowitz, JD, 1996)
"The effects of aspirin on coronary hemodynamics and transcardiac concentrations of thromboxane B2 (the stable metabolite of thromboxane A2) were determined at rest and during pacing-induced myocardial ischemia in 11 patients with coronary disease."3.67Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia. ( Addonizio, VP; Fisher, CA; Harken, AH; Hirshfeld, JW; Laskey, WK; Martin, JL; Untereker, WJ, 1985)
" This study describes the consequences of acute prostaglandin synthesis inhibition on the hemodynamic effects of nitroglycerin in patients with stable angina pectoris."3.67[Hemodynamic effects of nitroglycerin following acute inhibition of prostaglandin synthesis]. ( Punzengruber, C; Silberbauer, K; Sinzinger, H, 1986)
"Between 1950 and 1975, 473 Rochester patients had the diagnosis of rheumatoid arthritis and received aspirin treatment."3.66Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. ( Fuster, V; Kurland, LT; Linos, A; O'Fallon, W; Whisnant, JP; Worthington, JW, 1978)
"Side effects, such as arrhythmia, angina pectoris, and nervous headache, were observed in the celecoxib 400 mg/d group."2.72[Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis]. ( Geng, HG; Li, SR; Sheng, JQ; Su, H; Yan, W; Yang, XY; Yu, DL; Zhang, YH, 2006)
" It is not clear if combining enoxaparin with glycoprotein IIb/IIIa inhibitors is as safe or as effective as the current standard combination of unfractionated heparin with glycoprotein IIb/IIIa inhibitors."2.71Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. ( Ardissino, D; Bilheimer, DW; Blazing, MA; Braunwald, E; Califf, RM; de Lemos, JA; DiBattiste, PM; Fox, KA; Gardner, LH; Hasselblad, V; Lewis, EF; Palmisano, J; Pfeffer, MA; Ramsey, KE; Snapinn, SM; Verheugt, FW; White, HD, 2004)
"Treatment with sarpogrelate in addition to aspirin and ticlopidine caused no major adverse cardiovascular events or hemorrhagic adverse effects during the 6-month follow-up period."2.71Sarpogrelate treatment reduces restenosis after coronary stenting. ( Fujita, M; Ho, M; Ishii, K; Miki, O; Miwa, K; Miyamoto, A; Mizuno, K; Tsukahara, R, 2003)
"When ticlopidine was given for 72 hours, TF levels were similar to normal laboratory values both in stable and unstable patients."2.69Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris. ( Ariëns, RA; Bernies, M; Bossi, IM; Brambilla, GM; Donatelli, F; Fajadet, J; Gregorini, L; Marco, I; Marco, J; Mari, D; Romano, SM; Somalvico, F, 2000)
"83%) and greater average stenosis of worst lesions at 6 months (74% vs."2.68Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs AC ( Folland, ED; Hartigan, PM; Parisi, AF, 1997)
"We conclude that patients with unstable angina pectoris have a similar outcome after two years whether they receive medical therapy alone or coronary bypass surgery plus medical therapy."2.66Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. ( Deupree, RH; Luchi, RJ; Scott, SM, 1987)
"The protocols varied widely in terms of medication and dosing choices, as well as listed contraindications to treatments."2.52Chest Pain of Suspected Cardiac Origin: Current Evidence-based Recommendations for Prehospital Care. ( Barger, JA; Brown, JF; Gilbert, GH; Koenig, KL; Rudnick, EM; Salvucci, AA; Savino, PB; Sporer, KA, 2015)
"The incidence of deep vein thrombosis or pulmonary embolism in more than 500 patients undergoing hip surgery was similar for these 3 treatments."2.40Triflusal. ( Goa, KL; McNeely, W, 1998)
"Thromboxane A2 is a potent stimulator of platelet aggregation and vasoconstriction and synthesis may be completely inhibited by a single oral dose of 150 mg acetylsalicylic acid or an intravenous dose of 100 mg."2.39Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction). ( Husted, SE; Vissinger, H; Winther, K, 1994)
"Unstable angina is a clinical syndrome characterized by increased rate and severity of angina pectoris attacks and, sometimes but not always, accompanied by ECG changes similar to those seen in coronary insufficiency."2.38Unstable angina: pathophysiology and drug therapy. ( Bleifeld, W, 1990)
"Five patients (5."1.51[The Pathways to Increase the Efficacy of Drug Therapy in Patients with Ischemic Heart Disease after Coronary Artery Bypass Grafting]. ( Barbarash, OL; Hryachkova, ON; Kashtalap, VV; Shibanova, IA; Zykov, MV, 2019)
"Although depressive disorders have been associated with increased risk of worse outcomes with cardiovascular diseases (CVDs), its relation with access to and quality of cardiovascular care is not well studied."1.48Impact of Depressive Disorder on Access and Quality of Care in Veterans With Prevalent Cardiovascular Disease. ( Butler, J; Lacey, M; Parikh, PB; Shroyer, AL; Srivastava, P, 2018)
"Aspirin resistance was defined as the mean platelet aggregation of > or = 70% with 10 mM ADP and the mean platelet aggregation of > or = 20% with 0."1.39Aspirin resistance in Thai patients with chronic stable angina. ( Chinthammitr, Y; Chotinaiwattarakul, C; Karevee, D; Panchavinnin, P; Phankingthongkum, R; Sumalee, C; Tresukosol, D; Tungsubutra, W; Wongpraparut, N, 2013)
"Stroke is an important clinical problem and some strokes are caused by a cardiac thrombus."1.3964-MDCT can depict the thrombi expanded from the left lower pulmonary vein to the left atrium in the patient with angina pectoris. ( Takeuchi, H, 2013)
"Aspirin resistance was measured by urinary 11-dehydro-thromboxane beta-concentrations with an enzyme immunoassay kit."1.38Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors. ( Darabian, M; Eskandarian, R; Ghorbani, R; Heshmatnia, J, 2012)
"Incidence of postoperative hemorrhage (early and delayed) was not significant (P = ."1.37Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications. ( Bariol, SV; Brooks, AJ; Drummond, M; Lau, HM; McDonald, C; Patel, MI; Raj, MD; Wang, AC; Woo, HH, 2011)
"Women with CHD also had a higher rate of cerebral ischemia than did men (27."1.36Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus. ( Gerhat, D; Handisurya, A; Hudson, S; Kamyar, MR; Kautzky-Willer, A; Lemmens-Gruber, R; Luger, A; Stemer, G, 2010)
"Sex disparities in the diagnosis and treatment of chest pain or suspected angina have been demonstrated in multiple clinical settings."1.36Influence of sex on the out-of-hospital management of chest pain. ( Armstrong, K; Facenda, K; Mechem, CC; Meisel, ZF; Peacock, N; Pollack, CV; Shofer, FS, 2010)
"Aspirin use was associated with a lower risk of cardiovascular events (adjusted hazard ratio, 0."1.35Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study. ( Berger, JS; Brown, DL; Burke, GL; Kostis, JB; Langer, RD; Oberman, A; Wassertheil-Smoller, S; Wong, ND, 2009)
"We histologically assessed thrombus formation, cellular elements, localization of TRX and of oxidized low density lipoprotein (ox-LDL), intraplaque hemorrhage, and transition metal iron (Fe(2+), Fe(3+)) deposition in these specimens."1.35Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage. ( Asada, Y; Hatakeyama, K; Imamura, T; Kitamura, K; Nakamura, H; Nishihira, K; Ogawa, H; Sato, Y; Yamashita, A; Yodoi, J, 2008)
"Aspirin was given as 160 mg/day and clopidogrel as 300 mg loading dose followed by 75 mg/day."1.35Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris. ( Agewall, S; Berglund, M; Gordon, A; Saha, S; Sylvén, C, 2008)
"Patients with complex coronary stenoses had a significantly (P<0."1.32Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. ( Christiansen, M; Cole, D; Cosin-Sales, J; Holt, DW; Kaminski, P; Kaski, JC; Overgaard, MT; Oxvig, C, 2004)
"More than 90% of coronary aneurysms are of atherosclerotic origin."1.31Nonatherosclerotic aneurysm of the left circumflex coronary artery presenting with accelerated angina pectoris: response to medical management--a case report. ( Dogan, OM; Khan, IA; Sacchi, TJ; Vasavada, BC, 2000)
"Aspirin was used regularly by 37% of those with CVD and by 13% of those with risk factors only Adjusted odds of regular aspirin use were significantly greater for individuals with CVD than for those with one CVD risk factor (odds ratio [OR] = 4."1.31Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. ( Fagot-Campagna, A; Narayan, KM; Rolka, DB, 2001)
"Neurological examination revealed paresis of the left arm."1.31[Spontaneous intraspinal epidural hematoma secondary to use of platelet aggregation inhibitors]. ( Hoch, A; Kilisek, L; Spring, A; Weber, J, 2001)
"History of untreated hypertension prior to the initial stroke (RR = 1."1.30Stroke recurrence among 30 days survivors of ischemic stroke in a prospective community-based study. ( Baranska-Gieruszczak, M; Czlonkowska, A; Hier, DB; Lechowicz, W; Ryglewicz, D, 1997)
"Platelet thrombus formation and whole blood platelet aggregation were measured in 18 stable coronary patients on three separate occasions: at baseline when receiving no active medications, after 7 days of receiving oral verapamil SR (240 mg/d), and after 7 days of receiving a combination of oral verapamil SR and aspirin (325 mg/d)."1.29Oral verapamil inhibits platelet thrombus formation in humans. ( Hung, J; L-Lacoste, L; Lam, JY; Waters, D, 1994)
" A dose-response relation was found between level of anger and overall CHD risk (P for trend, ."1.29A prospective study of anger and coronary heart disease. The Normative Aging Study. ( Kawachi, I; Sparrow, D; Spiro, A; Vokonas, P; Weiss, ST, 1996)
"A 23-year-old male with bronchial asthma developed eosinophilia (eosinophils greater than 2,000/mm3) and was observed at our hospital."1.28[Acute myocardial injury and repeated angina pectoris-like attacks in a young patient with Churg-Strauss syndrome]. ( Arai, Y; Fukushima, N; Isokane, N; Miyamoto, Y; Sano, Y; Suzuki, N, 1991)

Research

Studies (320)

TimeframeStudies, this research(%)All Research%
pre-199092 (28.75)18.7374
1990's84 (26.25)18.2507
2000's102 (31.88)29.6817
2010's41 (12.81)24.3611
2020's1 (0.31)2.80

Authors

AuthorsStudies
Pavão, RB1
Moreira, HT1
Pintya, AO1
Haddad, JL1
Badran, AV1
Lima-Filho, MO1
Lago, IM1
Chierice, JRA1
Schmidt, A1
Marin-Neto, JA1
Kim, JB1
Choi, BG1
Rha, SW1
Seo, HS1
Choi, SY1
Byun, JK1
Na, JO1
Choi, CU1
Kim, EJ1
Park, CG1
Oh, DJ1
Chang, AM1
Litt, HI1
Snyder, BS1
Gatsonis, C1
Greco, EM1
Miller, CD1
Singh, H1
O'Conor, KJ1
Hollander, JE1
Fujimoto, W1
Sawada, T1
Toba, T1
Takahashi, Y1
Miyata, T1
Oishi, S1
Osue, T1
Onishi, T1
Takaya, T1
Shimane, A1
Taniguchi, Y1
Kawai, H1
Yasaka, Y1
Grinshtein, YI1
Kosinova, AA1
Grinshtein, IY1
Subbotina, TN1
Savchenko, AA1
Qureshi, R1
Kao, L1
Gupta, RP1
Srivastava, P1
Butler, J1
Shroyer, AL1
Lacey, M1
Parikh, PB1
Almas, A1
Ghazni, MS1
Hashmani, S1
Mushtaq, Z1
Barbarash, OL1
Kashtalap, VV1
Zykov, MV1
Hryachkova, ON1
Shibanova, IA1
Deo, SV1
Dunlay, SM1
Shah, IK1
Altarabsheh, SE1
Erwin, PJ1
Boilson, BA1
Park, SJ1
Joyce, LD1
Loenko, VB1
Sorokina, EA1
Faĭl', IL1
Smialovskiĭ, DV1
Takeuchi, H1
Phankingthongkum, R1
Panchavinnin, P1
Chinthammitr, Y1
Tresukosol, D1
Chotinaiwattarakul, C1
Tungsubutra, W1
Wongpraparut, N1
Karevee, D1
Sumalee, C1
Puchin'ian, NF1
Furman, NV1
Dovgalevskiĭ, IaP1
Martínez-Quintana, E1
Medina-Gil, JM1
Rodríguez-González, F1
Garay-Sánchez, P1
Limiñana, JM1
Saavedra, P1
Tugores, A1
López Mínguez, JR1
Nogales Asensio, JM1
Doncel Vecino, LJ1
Sandoval, J1
Romany, S1
Martínez Romero, P1
Fernández Díaz, JA1
Fernández Portales, J1
González Fernández, R1
Martínez Cáceres, G1
Merchán Herrera, A1
Alfonso Manterola, F1
Jeger, RV1
Pfisterer, ME1
Sørensen, R1
von Felten, S1
Alber, H1
Bonetti, PO1
Eberli, F1
Erne, P1
Pedrazzini, G1
Rickli, H1
Galatius, S1
Kaiser, CA2
Wada, N1
Okazaki, S1
Kobayashi, S1
Hashizume, K1
Hori, J1
Azumi, M1
Kita, M1
Iwata, T1
Matsumoto, S1
Kakizaki, H1
Ichikawa, M1
Takei, Y1
Hamasaki, T1
Kijima, Y1
Wei, YQ1
Wang, DG1
Yang, H1
Cao, H1
Yildiz, BS1
Ozkan, E1
Esin, F1
Alihanoglu, YI1
Ozkan, H1
Bilgin, M1
Kilic, ID1
Ergin, A1
Kaftan, HA1
Evrengul, H1
Savino, PB1
Sporer, KA1
Barger, JA1
Brown, JF1
Gilbert, GH1
Koenig, KL1
Rudnick, EM1
Salvucci, AA1
Navarro, MA1
Gosch, KL1
Spertus, JA2
Rumsfeld, JS1
Ho, PM1
Huang, J1
Tang, X1
Ye, F1
He, J1
Kong, X1
Godfrey, A1
Cajigas, HR1
Gao, L1
Li, YJ1
Chen, KY1
Cuisset, T2
Hamilos, M2
Sarma, J1
Sarno, G1
Wyffels, E1
Vanderheyden, M1
Barbato, E3
Bartunek, J2
De Bruyne, B2
Wijns, W3
Walter, T1
Szabo, S1
Kazmaier, S1
Swoboda, S1
Suselbeck, T1
Brueckmann, M1
Borggrefe, M2
Beyer, ME1
Hoffmeister, HM1
Lim, SY1
Kim, KS1
Joo, SJ1
Jeong, MH2
Schneider, DJ1
Sobel, BE1
Weintraub, WS1
Kolm, P1
Maron, DJ1
Zhang, Z1
Jurkovitz, C1
Zhang, W1
Hartigan, PM2
Lewis, C1
Veledar, E1
Bowen, J1
Dunbar, SB1
Deaton, C1
Kaufman, S1
O'Rourke, RA1
Goeree, R1
Barnett, PG1
Teo, KK1
Boden, WE1
Mancini, GB2
Ramsdale, DR1
Rao, A1
Asghar, O1
Ramsdale, KA1
McKay, E1
Frere, C1
Quilici, J1
Uhry, S1
Morange, PE1
Mouret, JP1
Gaborit, B1
Bali, L1
Moro, PJ1
Lambert, M1
Bonnet, JL1
Mrdovic, I1
Perunicic, J1
Asanin, M1
Matic, M1
Vasiljevic, Z1
Ostojic, M1
Hokimoto, S1
Matsui, K1
Oshima, S1
Noda, K1
Kaikita, K1
Sumida, H1
Sugiyama, S1
Ogawa, H3
Ranjith, MP1
Divya, R1
Mehta, VK1
Krishnan, MG1
KamalRaj, R1
Kavishwar, A1
Stellos, K1
Bigalke, B1
Stakos, D1
Henkelmann, N1
Gawaz, M2
Berger, JS1
Brown, DL1
Burke, GL1
Oberman, A1
Kostis, JB1
Langer, RD1
Wong, ND1
Wassertheil-Smoller, S1
Meisel, ZF1
Armstrong, K1
Mechem, CC1
Shofer, FS1
Peacock, N1
Facenda, K1
Pollack, CV1
Xue, F1
Yang, XJ1
Cheng, XJ1
Hui, J1
Jiang, TB1
Chen, T1
Liu, ZH1
Song, JP1
Jiang, WP1
Muller, O1
Ulrichts, H1
Mangiacapra, F2
Holz, JB1
Ntalianis, A1
Trana, C1
Dierickx, K1
Vercruysse, K1
Kim, SS1
Kim, HK1
Kim, MC1
Cho, KH1
Lee, MG1
Ko, JS1
Park, KH1
Sim, DS1
Yoon, NS1
Yoon, HJ1
Park, HW1
Kim, JH1
Hong, YJ1
Ahn, YK1
Cho, JG1
Park, JC1
Kang, JC1
Dvir, D1
Battler, A1
Batyraliev, TA1
Fettser, DV1
Samko, AN1
Sidorenko, BA1
Menown, IB1
Kautzky-Willer, A1
Kamyar, MR1
Gerhat, D1
Handisurya, A1
Stemer, G1
Hudson, S1
Luger, A1
Lemmens-Gruber, R1
Peace, AJ1
Raj, MD1
McDonald, C1
Brooks, AJ1
Drummond, M1
Lau, HM1
Patel, MI1
Bariol, SV1
Wang, AC1
Woo, HH1
Eskandarian, R1
Darabian, M1
Heshmatnia, J1
Ghorbani, R1
Elgin, U1
Sen, E1
Teke, MY1
Tirhis, H1
Ozturk, F1
Soejima, H1
Kishikawa, H1
Linares Vicente, JA1
Pérez, JO1
Lacasa, RC1
Plummer, W1
Macchi, L1
Christiaens, L1
Brabant, S1
Sorel, N1
Allal, J1
Mauco, G1
Brizard, A1
Almagor, M1
Keren, A1
Banai, S1
Toutouzas, K1
Di Mario, C1
Falotico, R1
Takagi, T1
Stankovic, G1
Albiero, R1
Corvaja, N1
Colombo, A2
Fujita, M1
Mizuno, K1
Ho, M1
Tsukahara, R1
Miyamoto, A1
Miki, O1
Ishii, K1
Miwa, K2
Borja, J1
Pérez, I1
De la Cruz, G1
Shakib, S1
George, A1
Wright, J1
Warren, E1
Reeves, J1
Bibby, J1
Harrison, S1
Dowswell, G1
Russell, I1
Russell, D1
Oganov, RG1
Lepakhin, VK1
Fitilev, SB1
Levin, AM1
Titarova, YY1
Sytchev, EN1
Kopp, CW1
Steiner, S1
Priglinger, U1
Christ, G1
Probst, P1
Maurer, G1
Minar, E1
Huber, K1
MATTHEWS, JC1
Neumann, FJ2
Kastrati, A2
Pogatsa-Murray, G1
Mehilli, J2
Bollwein, H1
Bestehorn, HP1
Schmitt, C1
Seyfarth, M1
Dirschinger, J2
Schömig, A2
Górecki, A1
Chamiec, T1
Bednarz, B1
Maciejewski, P1
Łukaszewicz, R1
Ceremuzyński, L1
Van der Planken, MG2
Claeys, MJ2
Vertessen, FJ1
Dilling, D2
Bosmans, JM2
Berneman, ZN1
Michiels, JJ2
Vrints, C1
Jaster, M1
Fuster, V3
Rosenthal, P1
Pauschinger, M1
Tran, QV1
Janssen, D1
Hinkelbein, W1
Schwimmbeck, P1
Schultheiss, HP1
Rauch, U1
Fleming, T1
Nissen, SE1
Borer, JS1
Armstrong, PW1
Cosin-Sales, J1
Christiansen, M1
Kaminski, P1
Oxvig, C1
Overgaard, MT1
Cole, D1
Holt, DW1
Kaski, JC1
Nagai, R1
Bradshaw, PJ1
Jamrozik, K1
Gilfillan, I1
Thompson, PL1
Genest, M1
Pochmalicki, G1
Blazing, MA1
de Lemos, JA1
White, HD1
Fox, KA1
Verheugt, FW1
Ardissino, D1
DiBattiste, PM1
Palmisano, J1
Bilheimer, DW1
Snapinn, SM1
Ramsey, KE1
Gardner, LH1
Hasselblad, V1
Pfeffer, MA1
Lewis, EF1
Braunwald, E1
Califf, RM3
Akbulut, M1
Ozbay, Y1
Karaca, I1
Ilkay, E1
Gundogdu, O1
Arslan, N1
Bolognese, L1
Ducci, K1
Angioli, P1
Falsini, G1
Liistro, F1
Baldassarre, S1
Burali, A1
Tran, H1
Anand, SS1
Grossmann, R1
Sokolova, O1
Schnurr, A1
Bonz, A1
Porsche, C1
Obergfell, A1
Lengenfelder, B1
Walter, U1
Eigenthaler, M1
Ferrari, E1
Benhamou, M1
Cerboni, P1
Marcel, B1
Karcz, M1
Ruzyłło, W1
Kounis, NG2
Kouni, SN1
Koutsojannis, CM1
Dibra, A1
Braun, S1
Hadamitzky, M1
Baum, H1
Schühlen, H1
Labarthe, B1
Théroux, P2
Angioï, M1
Ghitescu, M1
Sun, JC1
Crowther, MA1
Warkentin, TE1
Lamy, A1
Teoh, KH1
Rzeczuch, K1
Szajn, G1
Jankowska, E1
Kaczmarek, A1
Derkacz, A1
Porada, A1
Telichowski, A1
Banasiak, W1
Ponikowski, P1
Crowe, B1
Abbas, S1
Meany, B1
de Haan, J1
Cahill, MR1
Kaneda, H1
Suzuki, J1
Hosokawa, G1
Tanaka, S1
Hiroe, Y1
Saito, S1
Hughes, P1
Hasenkam, JM1
Severinsen, IK1
Steinbrüchel, DA1
Boztosun, B1
Gunes, Y1
Kirma, C1
Barutcu, I1
van Werkum, JW1
Heestermans, AA1
Jaarsma, W1
Hautvast, RW1
de Boer, MJ1
ten Berg, JM1
Sheng, JQ1
Li, SR1
Yang, XY1
Zhang, YH1
Su, H1
Yu, DL1
Yan, W1
Geng, HG1
Serebruany, VL1
Midei, MG1
Meilman, H1
Malinin, AI1
Lowry, DR1
Smith, C1
Damås, JK1
Otterdal, K1
Øie, E1
Sandberg, WJ1
Yndestad, A1
Waehre, T1
Scholz, H1
Endresen, K1
Olofsson, PS1
Halvorsen, B1
Gullestad, L1
Frøland, SS1
Hansson, GK1
Aukrust, P1
Prasan, AM1
Bhagwandeen, R1
Solanki, VJ1
Freedman, SB1
Brieger, D1
Ioannidis, TI1
Mazarakis, A1
Notaras, SP1
Karpeta, MZ1
Tsintoni, AC1
Kounis, GN1
Rallis, DG1
Krüth, P1
Heer, T1
Senges, J1
Zeymer, U1
Pamukcu, B1
Oflaz, H1
Onur, I1
Oncul, A1
Ozcan, M1
Umman, B1
Mercanoglu, F1
Meric, M1
Nisanci, Y1
Saha, S1
Berglund, M1
Sylvén, C1
Gordon, A1
Agewall, S1
Karlsson, G1
Rehman, J1
Kalaria, V1
Breall, JA1
Majdoub, MA1
Sauguet, A1
Tchetche, D1
Ducrocq, G1
Benamer, H1
Himbert, D1
Aubry, P1
Feldman, LJ1
Steg, PG1
Juliard, JM1
Schneider, CA1
Erdmann, E1
Inami, N1
Nomura, S1
Kimura, Y1
Yamada, K1
Nakamori, H1
Takahashi, N1
Fukuhara, S1
Iwasaka, T1
Kishida, H1
Smedema, JP1
Berlion, AE1
Morkel, H1
Friedewald, VE1
King, SB2
Pepine, CJ2
Vetrovec, GW1
Roberts, WC1
Naimushin, A1
Livneh, A1
Nielsen, AA1
Veien, KT1
Jørgensen, LG1
Buck, TC1
Brandslund, I1
Christensen, C1
Nishihira, K1
Yamashita, A1
Imamura, T1
Hatakeyama, K1
Sato, Y1
Nakamura, H1
Yodoi, J1
Kitamura, K1
Asada, Y1
Matsumoto, M1
Suehiro, K1
Kubo, Y1
Onoue, G1
Komatsubara, I1
Seito, T1
Morimoto, N1
Shiraishi, K1
Kasai, S1
Hagioka, S1
Naito, H1
Nagae, M1
Marshall, AJ1
Epstein, SE1
Palmeri, ST1
Caruzzo, C1
Sechi, A1
Monti, C1
Campagna, G1
Spinnler, MT1
Sanborn, TA1
Faxon, DP2
Kellett, MA2
Ryan, TJ1
Thornton, MA1
Gruentzig, AR1
Hollman, J1
Douglas, JS1
Hayashi, H1
Kisamori, K1
Kaneko, M1
Masumura, Y1
Kamikawa, T1
Kobayashi, A1
Suzuki, Y1
Yamazaki, N1
Yamaguchi, T1
Harada, Y1
Eichner, ER1
Rivey, MP1
Alexander, MR1
Taylor, JW1
Willerson, JT3
Campbell, WB1
Winniford, MD1
Schmitz, J1
Apprill, P1
Firth, BG1
Ashton, J1
Smitherman, T1
Bush, L1
Buja, LM1
Lewy, RI1
Born, GV2
Elwood, PC1
Fisher, LD1
Kennedy, JW1
Gazes, PC1
De Vita, C1
Passamani, ER1
Lands, WE1
Pitt, BW1
Culp, BR1
Handin, RI2
Alexander, RW1
Robertson, RM1
Robertson, D1
Roberts, LJ1
Maas, RL1
FitzGerald, GA3
Friesinger, GC1
Oates, JA1
van de Loo, J1
Frishman, WH3
Almazov, VA1
Vashkinel', VK1
Safronnikov, LV1
Lapotnikov, VA1
Petrov, MN1
Zdichynec, B1
Kambara, H1
Kawai, C1
Delanoe, G1
Green, LH1
Seroppian, E1
Weiss, HJ1
Mehta, J1
Mehta, P1
Conti, CR1
Meier, B2
Grover, GJ1
Schumacher, WA1
Ogletree, ML1
Magnani, B1
Semprini, F1
Montalescot, G2
Hargreaves, MR1
Firoozan, S1
Forfar, JC1
Modesti, PA3
Colella, A1
Cecioni, I1
Costoli, A1
Biagini, D1
Migliorini, A1
Neri Serneri, GG5
Zavecz, JH1
Bueno, O1
Dittel, M2
Haushofer, A2
Spiel, R1
Halbmayer, WM2
Prachar, H2
Fischer, M2
Mlczoch, J2
McMurray, J1
Rankin, A1
Bonnier, JJ1
Post, D1
Shetty, K1
Lasserre, B1
Périat, M1
Maclouf, J1
Drobinski, G1
Salloum, J1
Grosgogeat, Y1
Thomas, D1
Winther, K1
Husted, SE1
Vissinger, H1
Gensini, GF4
Poggesi, L2
Rostagno, C2
Boddi, M2
Gori, AM1
Martini, F1
Ieri, A2
Margheri, M2
Wallén, NH2
Held, C2
Rehnqvist, N2
Hjemdahl, P2
L-Lacoste, L1
Lam, JY1
Hung, J1
Waters, D1
Goodnight, SH1
Coull, BM1
McAnulty, JH1
Taylor, LM1
Ilia, R1
Kolanski, D1
Setaro, J1
Brennan, J1
Cabin, H1
Cleman, M1
Remetz, M1
Szczeklik, A1
Musial, J1
Undas, A1
Swadzba, J1
Gora, PF1
Piwowarska, W1
Duplaga, M1
Williams, S1
Fatah, K2
Ivert, T2
Blombäck, M2
Reininger, A1
Chirkov, YY1
Horowitz, JD1
Beving, H1
Albåge, A1
Kawachi, I1
Sparrow, D1
Spiro, A1
Vokonas, P1
Weiss, ST1
Doughty, RN1
Sharpe, N1
Jackson, G1
Folland, ED1
Parisi, AF1
Herlitz, J1
Albertsson, P1
Brandrup-Wognsen, G1
Emanuelsson, H2
Haglid, M1
Hartford, M1
Hjalmarson, A1
Karlson, BW1
Karlsson, T1
Sandén, W1
Ryglewicz, D1
Baranska-Gieruszczak, M1
Czlonkowska, A1
Lechowicz, W1
Hier, DB1
Wenger, NK1
van de Loo, A1
Nauck, M1
Noory, E1
Just, H1
Wollschläger, H1
Eccles, M1
Freemantle, N1
Mason, J1
Oemrawsingh, PV1
Tuinenburg, JC1
Schalij, MJ1
Jukema, JW1
Reiber, JH1
Bruschke, AV1
McNeely, W1
Goa, KL1
Asirvatham, S1
Sebastian, C1
Thadani, U1
Berglund, U1
Lindahl, T1
Serruys, PW1
van Hout, B1
Bonnier, H1
Legrand, V1
Garcia, E1
Macaya, C1
Sousa, E1
van der Giessen, W1
Seabra-Gomes, R1
Kiemeneij, F1
Ruygrok, P1
Ormiston, J1
Fajadet, J2
Haude, M2
Klugmann, S1
Morel, MA1
Alvarez, JM1
Harper, RW1
Peverill, RE1
Nyberg, G1
Caidahl, K1
Kharitonova, N1
Petersson, AS1
Chiamvimonvat, V1
Sternberg, L1
Bing, M1
Abel, RL1
Pendergrass, P1
Malone, M1
Sabharwal, K1
McCauley, C1
Petticrew, M1
Turner-Boutle, M1
Sheldon, T1
McTaggart, D1
Ikonomidis, I1
Andreotti, F2
Economou, E1
Stefanadis, C2
Toutouzas, P2
Nihoyannopoulos, P1
de Rosis, F1
Grasso, F1
Berry, DC1
Jenkins, NP1
Meyer, MI1
Kuhn, M1
Bühler, H1
Bertschinger, P1
Bouvy, ML1
Heerdink, ER1
Klungel, OH1
de Boer, A1
Stuurman-Bieze, AG1
Leufkens, HG1
Tanasescu, S1
Lévesque, H1
Thuillez, C1
Karila-Cohen, D1
Gabriel Steg, P1
Foussas, S1
Alexopoulos, D1
Olympios, C1
Voudris, V1
Hatzimiltiadis, S1
Sionis, D1
Vavouranakis, E1
Vrahatis, A1
Fakiolas, C1
Pissimisis, E1
Stefanidis, A1
Zairis, M1
Pavlides, G1
Vitakis, S1
Louridas, G1
Cokkinos, D1
Suzuki, S1
Matsuo, T1
Kobayashi, H1
Matsuo, M1
Shimamo, C1
Koide, M1
Sakamoto, S1
Le Quan Sang, KH1
Le Feuvre, C1
Brunet, A1
Pham, TD1
Metzger, JP1
Vacheron, A1
Devynck, MA1
Bochkareva, EV1
Kucheriavaia, NG1
Kokurina, EV1
Metelitsa, VI1
Kondrat'ev, VV1
Gurfinkel, EP2
Santopinto, J1
Bozovich, GE1
Quispe, A1
Strinna, A1
Mautner, B2
Khan, IA1
Dogan, OM1
Vasavada, BC1
Sacchi, TJ1
Delahaye, JP1
Guize, L1
Ducimetière, P1
Consoli, SM1
Kolsky, H1
Raynaud, P1
Walch, JM1
Paul-Dauphin, A1
Duprat-Lomon, I1
Altman, R1
Scazziota, A1
Heguilen, R1
Marco, J1
Ariëns, RA1
Bossi, IM1
Marco, I1
Bernies, M1
Romano, SM1
Donatelli, F1
Brambilla, GM1
Somalvico, F1
Mari, D1
Gregorini, L1
Peter, K1
Nordt, T1
Bode, C1
Fischetti, D1
Sciahbasi, A1
Leone, AM1
Niccoli, G1
Schiavoni, G1
Trani, C1
Mazzari, MA1
Hézard, N1
Metz, D1
Garnotel, R1
Droullé, C1
Potron, G1
Nguyen, P1
Rolka, DB1
Fagot-Campagna, A1
Narayan, KM1
Naber, CK1
Rahman, YA1
Erbel, R1
Baumgart, D1
Diener, HC2
Darius, H2
Bertrand-Hardy, JM2
Humphreys, M2
McCarty, D1
Walsh, SJ1
Adgey, AA1
Olson, J1
Huntington, J1
Weber, J1
Hoch, A1
Kilisek, L1
Spring, A1
Fihn, SD1
Williams, SV1
Daley, J1
Gibbons, RJ1
Gheeraert, PJ1
Henriques, JP1
De Buyzere, ML1
De Pauw, M1
Taeymans, Y1
Zijlstra, F1
Denktas, AE1
Bayes-Genis, A1
Schwartz, RS1
Bittl, JA1
Chaitman, BR1
Feit, F1
Kimball, W1
Topol, EJ3
Poerner, TC1
Kralev, S1
Voelker, W1
Sueselbeck, T1
Latsch, A1
Pfleger, S1
Schumacher, B1
Haase, KK1
Knottenbelt, C1
Brennan, PJ1
Meade, TW1
Vertessen, F1
Vrints, CJ1
Aviles, RJ1
Askari, AT1
Lindahl, B1
Wallentin, L1
Jia, G1
Ohman, EM1
Mahaffey, KW1
Newby, LK1
Simoons, ML1
Berger, P1
Lauer, MS1
Saleh, N1
Hansson, LO1
Kohut, M1
Nilsson, T1
Tornvall, P1
Arrigo, F1
Coglitore, S1
Virga, T1
Giannetto, M1
Bramanti, B1
Melluso, C1
Consolo, F1
Atanasov, K1
Yovkova, T1
Tzvetkova, T1
Davis, JW1
Lewis, HD3
Phillips, PE1
Schwegler, RA1
Yue, KT1
Hassanein, KR1
Gantmacher, ML1
Verstraete, M2
Evangelisti, GB1
Faggioli, F1
Garagnani, A1
Lama, G1
Linos, A1
Worthington, JW1
O'Fallon, W1
Whisnant, JP1
Kurland, LT1
Stornello, M1
Aloisi, B1
Stuto, A1
Vinci, E1
Bozzanca, L1
Christodoulou, J1
Weksler, B1
Smithen, C1
Killip, T1
Scheidt, S1
Guyton, JR1
Wu, KK1
Hoak, JC1
Willard, JE1
Lange, RA1
Hillis, LD1
Trenkwalder, P1
Lydtin, H1
Kübler, W1
Hoberg, E1
Weber, R1
Juul-Möller, S1
Edvardsson, N1
Jahnmatz, B1
Rosén, A1
Sørensen, S1
Omblus, R1
Klein, W2
Eber, B2
Fruhwald, F1
Akhmedzhanov, MIu1
Ezhova, LV1
Arkhangel'skiĭ, VV1
Roux, S1
Christeller, S1
Lüdin, E1
Kerins, DM1
Ferlito, S1
Suzuki, N1
Arai, Y1
Miyamoto, Y1
Isokane, N1
Fukushima, N1
Sano, Y1
Kirichenko, AA1
Dan'shina, OE1
Repinskaia, NP1
Ioseliani, DG1
Rishko, NV1
Ridker, PM3
Manson, JE3
Buring, JE3
Goldhaber, SZ2
Hennekens, CH3
Carpenter, AL1
Caravalho, J1
Trotta, F1
Casolo, GC1
Bini, M1
Bleifeld, W1
Morrison, DA1
Boudoulas, H1
Gaziano, JM2
Atakhanova, LZ1
Mazurov, AV1
Katsenovich, ER1
Karpov, IuA1
Kostko, SZ1
Repin, VS1
Ruda, MIa1
Williams, DO1
Roberts, R1
Joelson, JM1
Ellis, SG1
Kleiman, NS1
Rutherford, JD1
Cohen, M1
Adams, PC1
Hawkins, L1
Bach, M1
Grobbee, DE1
Stampfer, MJ1
Taylor, JO1
Bichan, NA1
Gol'dberg, GA1
Kristensen, SD1
Bath, PM1
Martin, JF1
Abbate, R2
Castellani, S1
Bonechi, F1
Carnovali, M1
Dabizzi, RP1
Dagianti, A1
Arata, L1
Vejar, M2
Fragasso, G1
Hackett, D2
Lipkin, DP1
Maseri, A2
Ciabattoni, G1
Patrono, C2
Schreiber, TL2
Macina, G2
Bunnell, P2
Tenney, RD1
McNulty, A2
Kikel, M2
Miller, DH2
Zola, BE1
Tracy, R1
Stump, D1
Brunelli, C1
Spallarossa, P1
Ianetti, M1
Galassi, AR1
Lipkin, D1
Caponnetto, S1
von Dohlen, TW1
Rogers, WB1
Frank, MJ1
Gratsianskiĭ, NA1
Resnekov, L1
Chediak, J1
Hirsh, J2
Silberberg, JS1
McGregor, M1
Charvat, J1
Kuruvilla, T1
Fluch, N1
Dusleag, J1
Weinrauch, V1
Rotman, B1
Gasser, R1
Kronberger-Schaffer, E1
Davì, G1
Catalano, I1
Spatola, A1
Alaimo, P1
Notarbartolo, A1
Cerbone, AM1
Strano, A1
Devereux, RB1
Tenney, R1
Cowley, M1
Zola, B1
Khimenko, PL1
Hugenholtz, PG2
Cohen, LS1
Luchi, RJ1
Scott, SM1
Deupree, RH1
Leeman, DE1
McCabe, CH1
Lorell, BH1
McKay, RG1
Varricchione, T1
Baim, DS1
Seth, A1
Perry, RA1
Shiu, MF1
van den Berg, EK1
Schmitz, JM1
Benedict, CR1
Malloy, CR1
Dehmer, GJ1
Hamad, JF1
Miller, KP1
Gershlick, AH1
Lyons, JP1
Wright, JE1
Sturridge, MF1
Layton, CA1
Balcon, R1
Ouimet, H1
McCans, J1
Latour, JG1
Joly, P1
Lévy, G1
Pelletier, E1
Juneau, M1
Stasiak, J1
deGuise, P1
Ahmad, RA1
Watson, RD1
Petch, MC1
Punzengruber, C1
Silberbauer, K1
Sinzinger, H1
Panetta, A1
Pinto, S1
Favilla, S1
Prisco, D1
Sakai, K1
Yamazaki, T1
Nakamura, Y1
Sugimoto, T1
Shimizu, Y1
Tanaka, T1
Takayama, Y1
Hayashi, T1
Ito, Y1
Abe, M1
Matsuda, M1
Ida, T1
Sakakibara, T1
Obunai, Y1
Rehr, RB1
DiSciascio, G1
Cowley, MJ1
Cairns, JA3
Hansen, JF1
Hansen, BF1
Lecompte, T1
Samama, M1
Orlov, VA1
Iakunin, GA2
Khishtovani, AI2
Myers, MG2
Singer, J2
Bates, ER1
Mickelson, JK1
Dmitriev, AA1
Kormer, AIa1
Brown, BG1
Cukingnan, RA1
DeRouen, T1
Goede, LV1
Wong, M1
Fee, HJ1
Roth, JA1
Carey, JS1
Sherry, S1
Ogawa, K1
Ito, T1
Gent, M1
Finnie, KJ1
Froggatt, GM1
Holder, DA1
Jablonsky, G1
Kostuk, WJ1
Melendez, LJ1
Courillon-Mallet, A1
Wautier, JL1
Martin, JL1
Fisher, CA1
Untereker, WJ1
Laskey, WK1
Hirshfeld, JW1
Harken, AH1
Addonizio, VP1
Kingdon, HS1
Weser, C1
Scheidler, K1
Loew, D1
Wellmer, HK1
Baer, U1
Merguet, H1
Rumpf, P1
Petersen, H1
Bromig, G1
Persch, WF1
Marx, FJ1
von Bary, SM1
Harkavy, J1

Clinical Trials (17)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Tailored Use of Tirofiban in Patients With Non-ST-elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention[NCT03114995]Phase 4140 participants (Actual)Interventional2012-02-01Completed
CSP #424 - Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation[NCT00007657]Phase 33,260 participants (Anticipated)Interventional1998-12-31Completed
Quality of Life and Achievement of Target of Treatment After Optimized Medical Treatment, Physical Training and Smoking Cessation With or Without Percutaneous Coronary Intervention in Patients With Stable Angina Pectoris.[NCT00825604]Phase 20 participants (Actual)Interventional2009-01-31Withdrawn (stopped due to Because of poor inclusion difficulties to find patient)
Impact of Coronary Artery Stenting on Quantitative Myocardial Blood Flow and Health Status[NCT04475094]75 participants (Anticipated)Observational2019-12-23Recruiting
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery[NCT03590769]Phase 19 participants (Actual)Interventional2017-06-01Completed
Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of the Glycoprotein IIb/IIIa Inhibition With Abciximab in Patients With ACS Undergoing Coronary Stenting After Pretreatment With a High Loading Dose of Clopidogrel (ISAR-REACT-2)[NCT00133003]Phase 42,022 participants (Actual)Interventional2003-03-31Completed
Acute Angioplasty (Primary PCI) Versus Traditional Early Invasive Treatment of Patients Presenting With NSTEMI (The Second Danish Non-ST-Elevation MI Trial - DaNSTEMI-2)[NCT00493584]14 participants (Actual)Interventional2008-03-31Terminated (stopped due to Due to insufficient patient inclusion the study has been stopped prematurely.)
Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Abciximab And Bivalirudin in Patients With Non-ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Interventions (ISAR-REACT-4)[NCT00373451]Phase 41,721 participants (Actual)Interventional2006-07-31Completed
Maintenance of an Antiaggregation by Acetylsalicylic Acid, Less or Equal to 250mg While a Extracorporeal Lithotripsy (ECL) Session on a Kidney Stone is Perfomed: Comparative Unicentric Prospective Study[NCT03437057]300 participants (Anticipated)Interventional2018-01-08Recruiting
Effect of Low Molecular Weight Heparin vs Unfractionated Heparin on Bleeding After Cardiac Surgery[NCT00420667]43 participants (Actual)Interventional2004-11-30Completed
Phase I/IIa Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2[NCT03333590]Phase 1/Phase 22 participants (Actual)Interventional2017-11-06Active, not recruiting
Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures[NCT05292846]Phase 4200 participants (Anticipated)Interventional2022-01-20Recruiting
A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation in High Risk Primary Prevention (Patients With Metabolic Syndrome)[NCT00272311]Phase 470 participants (Actual)Interventional2006-10-31Completed
A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation & Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease)[NCT00272337]Phase 437 participants (Actual)Interventional2006-10-31Completed
Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286]Phase 440 participants (Actual)Interventional2009-05-31Completed
[NCT00000500]Phase 30 participants Interventional1981-09-30Completed
Effect of Information on Placebo in the Informed Consent on the Trial Outcomes and Participant Blinding[NCT04182295]89 participants (Actual)Interventional2019-10-07Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Area Under Curve of Serial Cardiac Biomarkers

An area under the curve of serial levels of Troponin I and creatine kinase-MB isoenzyme during 36 hours (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours

,,
InterventionHours*ng/ml (Median)
Troponin Icreatine kinase-MB isoenzyme
Control C1 (High Platelet Reactivity - no Tirofiban)38.092.7
Control C2 (Low Platelet Reactivity - no Tirofiban)121.4185.6
Group A (High Platelet Reactivity - Tirofiban)197.2252.5

Percentage of Participants With Periprocedural Myonecrosis

"Percentage of participants with periprocedural myonecrosis under the criteria described below.~When the cardiac biomarkers before the procedure were within the 99th percentile upper reference limit (URL), more than a 5-fold elevation in the URL within 12 hours after percutaneous coronary intervention (PCI) was defined as periprocedural myonecrosis. If the cardiac biomarker level was already above the 99th percentile URL before the procedure and the trend was stationary or decreasing, a ≥20% increase compared to the previous level was considered periprocedural myonecrosis. If the trend was still increasing, the levels at the post-6 hour and 12-hour were compared to determine periprocedural myonecrosis." (NCT03114995)
Timeframe: 0,6,12,18,24,30,36 hours

,,
InterventionParticipants (Count of Participants)
Troponin Icreatine kinase-MB isoenzyme
Control C1 (High Platelet Reactivity - no Tirofiban)1510
Control C2 (Low Platelet Reactivity - no Tirofiban)2625
Group A (High Platelet Reactivity - Tirofiban)1611

Expression of GALGT2 as Demonstrated by Immunofluorescent Staining With Anti-CT Epitope Antibodies or WFA Lectin in Muscle Biopsy Sections at 120 Days Post Injection (Cohort 1) and 90 Days Post-injection (Cohort 2).

Percentage of fibers expressing GALGT2 in each biopsy sample. (NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1)

InterventionPercentage of Positive Fibers (Number)
Cohort 1 (Minimal Efficacious Dose)1.95
Cohort 21.72

GALGT2 Protein Expression Quantified by Western Blot and Assessed by Densitometry in Muscle Biopsy Tissue at 120 Days Post-injection (Cohort 1) and 90 Days Post-injection (Cohort 2)

(NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1)

Interventionng/mg total protein (Number)
Cohort 1 (Minimal Efficacious Dose)12
Cohort 214.6

Number of Unanticipated Grade III or Higher Treatment-Related Toxicities

(NCT03333590)
Timeframe: 2 years

Interventionevents (Number)
Cohort 1 (Minimal Efficacious Dose)0
Cohort 20

Number of Meters Walked During the 6 Minute Walk Test

(NCT03333590)
Timeframe: Day 90 (Cohort 2) and Day 120 (Cohort 1) and Day 180 for both cohorts

,
Interventionmeters (Number)
Day 90 (Cohort 2) /Day 120 (Cohort 1)Day 180
Cohort 1 (Minimal Efficacious Dose)320324
Cohort 2 (Minimal Efficacious Dose)405416

Score of Muscle Function Using the The North Star Ambulatory Assessment (NSAA).

The NSAA provides a score between 0 and 34 where higher numbers represent greater muscle function. (NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1) and both Cohorts at Day 180, Months 12, 18 and 24

,
Interventionscore on a scale (Number)
Day 90/Day 120Day 180Month 12Month 18Month 24
Cohort 1 (Minimal Efficacious Dose)16141062
Cohort 22123232323

Strength of the Bilateral Knee Flexors and Extensors During the Maximal Voluntary Isometric Strength Test.

(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1) and both Cohorts at Day 180, Months 12, 18 and 24

,
Interventionkg (Number)
Day 90/Day 120-Right Knee ExtensionDay 90/Day 120-Right Knee FlexionDay 90/Day 120- Left Knee ExtensionDay 90/Day 120-Left Knee FlexionDay 180-Right Knee ExtensionDay 180-Right Knee FlexionDay 180-Left Knee ExtensionDay 180-Left Knee FlexionMonth 12-Right Knee ExtensionMonth 12-Right Knee FlexionMonth 12-Left Knee ExtensionMonth 12-Left Knee FlexionMonth 18-Right Knee ExtensionMonth 18-Right Knee FlexionMonth 18-Left Knee ExtensionMonth 18-Left Knee FlexionMonth 24-Right Knee ExtensionMonth 24-Right Knee FlexionMonth 24-Left Knee ExtensionMonth 24-Left Knee Flexion
Cohort 1 (Minimal Efficacious Dose)7.426.068.786.127.136.18.666.697.495.677.55.324.556.114.966.265.064.416.934.17
Cohort 27.048.125.98.49.734.248.195.259.855.858.025.127.676.897.346.089.815.045.214.87

Time Taken to Walk 100 Meters During the 100 Meter Walk Test.

(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1); both Cohorts at Day 180, Months 12, 18 and Cohort 2 at Month 24

Interventionseconds (Number)
Day 90/Day 120Day 180Month 12Month 18
Cohort 1 (Minimal Efficacious Dose)98.2110.9144.5167.8

Time Taken to Walk 100 Meters During the 100 Meter Walk Test.

(NCT03333590)
Timeframe: Days 90 (Cohort 2), 120 (Cohort 1); both Cohorts at Day 180, Months 12, 18 and Cohort 2 at Month 24

Interventionseconds (Number)
Day 90/Day 120Day 180Month 12Month 18Month 24
Cohort 256.144.944.765.648.4

Change in Nitric Oxide Formation From Baseline to 3 Months

Changes in Heme oxygenase (HO-1) a downstream target of nitric oxide (NO) formation. (NCT00272311)
Timeframe: Baseline to 3 Months (90-97 days)

Interventionng/mL (Mean)
Arm 1 of 5 Randomized Treatment Arms27.6
Arm 2 of 5 Randomized Treatment Arms27.0
Arm 3 of 5 Randomized Treatment Arms31.4
Arm 4 of 5 Randomized Treatment Arms25.7
Arm 5 of 5 Randomized Treatment Arms28.3

Change in Nitric Oxide Formation From Baseline to 3 Months.

Heme oxygenase a downstream target of nitric oxide formation (NCT00272337)
Timeframe: Baseline to 3 Months (90-97 days)

Interventionng/mL (Mean)
1 of 5 Randomized Treatment Arms10.0
2 of 5 Randomized Treatment Arms11.2
3 of 5 Randomized Treatment Arms10.0
4 of 5 Randomized Treatment Arms11.0
5 of 5 Randomized Treatment Arms9.6

Reviews

61 reviews available for aspirin and Angor Pectoris

ArticleYear
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
    Journal of cardiac surgery, 2013, Volume: 28, Issue:2

    Topics: Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Bypass; Drug Therapy, Combination; Graft Occl

2013
Chest Pain of Suspected Cardiac Origin: Current Evidence-based Recommendations for Prehospital Care.
    The western journal of emergency medicine, 2015, Volume: 16, Issue:7

    Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Angina Pectoris; Aspirin; California; Clinical Prot

2015
Clinical Therapeutic Effects of Aspirin in Combination with Fufang Danshen Diwan, a Traditional Chinese Medicine Formula, on Coronary Heart Disease: A Systematic Review and Meta-Analysis.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 39, Issue:5

    Topics: Angina Pectoris; Aspirin; Cardiotonic Agents; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Di

2016
Conventional and novel drug therapeutics to relief myocardial ischemia.
    Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4

    Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors

2010
Contemporary management of coronary heart disease.
    The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1

    Topics: Acute Coronary Syndrome; Administration, Oral; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti

2010
Sirolimus-eluting stents: a review of experimental and clinical findings.
    Zeitschrift fur Kardiologie, 2002, Volume: 91 Suppl 3

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Animals; Aspirin; Clopidogrel; Coronary Angiography

2002
Choosing a drug from within a class.
    Australian family physician, 2003, Volume: 32, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Aspirin; Australia; Decision Making; Drug Costs;

2003
[Recent progress in diagnosis of and therapy for angina pectoris].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2004, Mar-10, Volume: 93, Issue:3

    Topics: Angina Pectoris; Aspirin; Biomarkers; Catheterization; Coronary Artery Bypass; Creatine Kinase; Crea

2004
[Acute coronary syndromes without ST segment elevation].
    Presse medicale (Paris, France : 1983), 2004, May-22, Volume: 33, Issue:9 Pt 1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Analgesics, Opioid; Angina Pectoris; Angiotensin-Convert

2004
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    JAMA, 2004, Oct-20, Volume: 292, Issue:15

    Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopido

2004
[Standard pharmacological therapy associated with percutaneous coronary interventions in patients with stable angina].
    Kardiologia polska, 2004, Volume: 61, Issue:11

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Fibrinolytic Agents; Hepar

2004
[Stable angina pectoris, angina pectoris of effort, stable angina pectoris of effort].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Sep-28, Volume: Suppl 5 Pt 2

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon; Aspirin; Circadian Rhythm; Diagn

2007
Drug therapy of hypertension and ischaemic heart disease.
    British journal of anaesthesia, 1981, Volume: 53, Issue:7

    Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; C

1981
Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.
    The American journal of cardiology, 1984, Dec-01, Volume: 54, Issue:10

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Animals; Antic

1984
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
    The American journal of medicine, 1984, Volume: 77, Issue:3

    Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosi

1984
Dipyridamole: a critical evaluation.
    Drug intelligence & clinical pharmacy, 1984, Volume: 18, Issue:11

    Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro

1984
[Interference in platelet-fibrinogen system for prevention and therapy of myocardial infarct].
    Deutsche medizinische Wochenschrift (1946), 1982, Jan-15, Volume: 107, Issue:2

    Topics: Angina Pectoris; Anticoagulants; Aspirin; Fibrinolysis; Humans; Myocardial Infarction; Recurrence

1982
Antiplatelet therapy in coronary heart disease.
    Hospital practice (Hospital ed.), 1982, Volume: 17, Issue:5

    Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disor

1982
[Blood thinning in heart patients].
    Therapeutische Umschau. Revue therapeutique, 1995, Volume: 52, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Aspirin; Atrial Fibrillation; Clini

1995
Pharmacologic therapy of angina pectoris.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1995, Volume: 147, Issue:5

    Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug

1995
Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris.
    BMJ (Clinical research ed.), 1994, Nov-19, Volume: 309, Issue:6965

    Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inh

1994
Prescribing for angina.
    The Practitioner, 1994, Volume: 238, Issue:1540

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Humans; Myocardial

1994
Low dose acetylsalicylic acid in the antithrombotic treatment of patients with stable angina pectoris and acute coronary syndromes (unstable angina pectoris and acute myocardial infarction).
    Pharmacology & toxicology, 1994, Volume: 74, Issue:3

    Topics: Administration, Oral; Angina Pectoris; Antithrombins; Aspirin; Humans; Injections, Intravenous; Male

1994
Antiplatelet therapy--Part I.
    The Western journal of medicine, 1993, Volume: 158, Issue:4

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cardiovascular Diseases; Coronary Artery Bypass; Coronar

1993
[Anticoagulation in cardiology].
    Annales de cardiologie et d'angeiologie, 1995, Volume: 44, Issue:10

    Topics: 4-Hydroxycoumarins; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial

1995
Optimal treatment of angina in older patients.
    Drugs & aging, 1996, Volume: 8, Issue:5

    Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angina Pectoris; Angioplasty, Balloon, Laser-Assiste

1996
Coronary heart disease: an older woman's major health risk.
    BMJ (Clinical research ed.), 1997, Oct-25, Volume: 315, Issue:7115

    Topics: Aged; Angina Pectoris; Aspirin; Cholesterol; Coronary Disease; Estrogen Replacement Therapy; Female;

1997
North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.
    BMJ (Clinical research ed.), 1998, Apr-25, Volume: 316, Issue:7140

    Topics: Angina Pectoris; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Consumer Product Safet

1998
Triflusal.
    Drugs, 1998, Volume: 55, Issue:6

    Topics: Adult; Angina Pectoris; Animals; Aspirin; Carotid Stenosis; Humans; In Vitro Techniques; Middle Aged

1998
Choosing the most appropriate treatment for stable angina. Safety considerations.
    Drug safety, 1998, Volume: 19, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspiri

1998
Coronary artery disease in women.
    Canadian family physician Medecin de famille canadien, 1998, Volume: 44

    Topics: Adult; Age Factors; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin-Converting En

1998
Cardiology 7. Stable angina pectoris: treatment and referral options.
    The Medical journal of Australia, 1999, Jul-05, Volume: 171, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti-Inflammator

1999
[Pharmacology of aspirin].
    La Revue de medecine interne, 2000, Volume: 21 Suppl 1

    Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Br

2000
[Aspirin and prevention of cardiovascular risk].
    La Revue de medecine interne, 2000, Volume: 21 Suppl 1

    Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Ste

2000
[Therapeutic inhibition of platelets in a acute coronary syndrome and in coronary intervention: mechanisms and clinical results].
    Zeitschrift fur Kardiologie, 2000, Volume: 89 Suppl 7

    Topics: Abciximab; Acute Disease; Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary;

2000
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
    Journal des maladies vasculaires, 2000, Volume: 25, Issue:5

    Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal

2000
Current management issues in angina.
    The Practitioner, 2001, Volume: 245, Issue:1622

    Topics: Angina Pectoris; Aspirin; Coronary Angiography; Diagnosis, Differential; Exercise Test; Humans; Hypo

2001
New approaches to the pharmacological treatment of angina.
    Current opinion in pharmacology, 2001, Volume: 1, Issue:2

    Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inh

2001
Antiplatelet agents: a review.
    Journal of the Royal Society of Medicine, 1979, Volume: 72, Issue:7

    Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi

1979
The use of aspirin in ischemic heart disease.
    The New England journal of medicine, 1992, Jul-16, Volume: 327, Issue:3

    Topics: Angina Pectoris; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Myocardial Revascularizat

1992
[Therapeutic possibilities, respective implications in silent ischemia].
    Zeitschrift fur Kardiologie, 1992, Volume: 81, Issue:4

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Coronary Artery Byp

1992
[Is it necessary to treat silent myocardial ischemia?].
    Acta medica Austriaca, 1992, Volume: 19, Issue:3

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Coronary Artery Bypass; Co

1992
Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis.
    Journal of the American College of Cardiology, 1992, Mar-01, Volume: 19, Issue:3

    Topics: Angina Pectoris; Aspirin; Chemotherapy, Adjuvant; Coronary Thrombosis; Female; Humans; Male; Meta-An

1992
The current role of platelet-active drugs in ischaemic heart disease.
    Drugs, 1991, Volume: 41, Issue:5

    Topics: Angina Pectoris; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhi

1991
[Platelet antiaggregants in the treatment of arterial thrombosis].
    Minerva cardioangiologica, 1991, Volume: 39, Issue:10

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery

1991
Unstable angina: pathophysiology and drug therapy.
    European journal of clinical pharmacology, 1990, Volume: 38 Suppl 1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Calcium Cha

1990
Unstable angina and thrombolysis.
    Chest, 1990, Volume: 97, Issue:4 Suppl

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Coronary Thrombosis; Heparin; Humans; Thrombolytic Thera

1990
Pathophysiology and management of unstable angina.
    Clinical cardiology, 1989, Volume: 12, Issue:7

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Aspirin; Electrocardiography; Hepari

1989
Antithrombotic agents in coronary artery disease.
    Chest, 1989, Volume: 95, Issue:2 Suppl

    Topics: Angina Pectoris; Anticoagulants; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Platelet

1989
Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategies.
    The Canadian journal of cardiology, 1989, Volume: 5, Issue:3

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Circulation; Humans;

1989
Calcium antagonists for angina pectoris.
    Annals of the New York Academy of Sciences, 1988, Volume: 522

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticoagulants; Aspirin; Calcium Channel Blockers; Hum

1988
Management of unstable angina soon after myocardial infarction.
    British journal of hospital medicine, 1988, Volume: 39, Issue:5

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Anticoagulants

1988
Platelets and antiplatelet therapy in ischemic heart disease.
    Current problems in cardiology, 1986, Volume: 11, Issue:2

    Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a

1986
An aspirin a day for unstable angina?
    Journal of clinical pharmacy and therapeutics, 1988, Volume: 13, Issue:4

    Topics: Angina Pectoris; Aspirin; Humans; Risk Factors

1988
Thrombosis in unstable angina: angiographic aspects.
    Cardiovascular clinics, 1987, Volume: 18, Issue:1

    Topics: Angina Pectoris; Angina, Unstable; Angiography; Arteries; Aspirin; Coronary Circulation; Coronary Di

1987
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cardiovascular clinics, 1987, Volume: 18, Issue:1

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Arte

1987
[Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology].
    Ugeskrift for laeger, 1987, Nov-02, Volume: 149, Issue:45

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Calcium Channel Blockers; Coronary Angiography; Coronary

1987
Effectiveness of anticoagulants.
    Seminars in thrombosis and hemostasis, 1986, Volume: 12, Issue:1

    Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood

1986
Clinical aspects of antiplatelet therapy.
    Seminars in hematology, 1985, Volume: 22, Issue:2

    Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal

1985
[Analogs of prostaglandin-related substances and inhibitors of their synthesis and metabolism. Clinical application: cardiovascular diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 1985, Volume: 43, Issue:3

    Topics: Angina Pectoris; Aspirin; Coronary Disease; Epoprostenol; Humans; Hypertension; Methacrylates; Myoca

1985
Cardiac manifestations due to hypersensitivity.
    Annals of allergy, 1970, Volume: 28, Issue:6

    Topics: Adams-Stokes Syndrome; Anaphylaxis; Angina Pectoris; Antigen-Antibody Complex; Arrhythmias, Cardiac;

1970

Trials

79 trials available for aspirin and Angor Pectoris

ArticleYear
Aspirin plus verapamil relieves angina and perfusion abnormalities in patients with coronary microvascular dysfunction and Chagas disease: a pilot non-randomized study.
    Revista da Sociedade Brasileira de Medicina Tropical, 2021, Volume: 54

    Topics: Angina Pectoris; Aspirin; Chagas Disease; Female; Humans; Male; Middle Aged; Perfusion; Quality of L

2021
Impact of Coronary Computed Tomography Angiography Findings on Initiation of Cardioprotective Medications.
    Circulation, 2017, 11-28, Volume: 136, Issue:22

    Topics: Acute Coronary Syndrome; Adult; Angina Pectoris; Aspirin; Clinical Decision-Making; Computed Tomogra

2017
[Potential utility of optic aggregometry for identification of patients with coronary heart disease resistant to acetylsalicylic acid].
    Klinicheskaia meditsina, 2013, Volume: 91, Issue:1

    Topics: Acute Disease; Adult; Angina Pectoris; Aspirin; Coronary Disease; Drug Resistance; Female; Humans; M

2013
A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:1

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; C

2014
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations.
    American heart journal, 2014, Volume: 168, Issue:5

    Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-El

2014
[Effects of supplementing qi and activating blood circulation method on platelet aggregation rate, adhesion rate and thromboxane B2 level in patients with stable angina pectoris and intolerable to aspirin].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2008, Volume: 28, Issue:4

    Topics: Aged; Angina Pectoris; Aspirin; Blood Circulation; Cell Adhesion; Drug Tolerance; Drugs, Chinese Her

2008
Effect of clopidogrel on adhesion molecules, hemostasis, and fibrinolysis in coronary heart disease.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:6

    Topics: Aged; Angina Pectoris; Aspirin; Cell Adhesion Molecules; Chronic Disease; Clopidogrel; Double-Blind

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of PCI on quality of life in patients with stable coronary disease.
    The New England journal of medicine, 2008, Aug-14, Volume: 359, Issue:7

    Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; C

2008
Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study.
    Thrombosis research, 2009, Volume: 124, Issue:1

    Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Arachidonic Acid; Aspirin; Blood Platelets; Clopidogre

2009
[Implantation of the paclitaxel-eluting stent Apollo in patients with stable angina pectoris: long-term angiographic and clinical results].
    Terapevticheskii arkhiv, 2010, Volume: 82, Issue:8

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronar

2010
Sarpogrelate treatment reduces restenosis after coronary stenting.
    American heart journal, 2003, Volume: 145, Issue:3

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cell Division; Coronary Angiography;

2003
Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:4

    Topics: Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; C

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
    JAMA, 2003, Sep-24, Volume: 290, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Catheterization; Clopidogrel; Female; Fibrinolytic Agents; Heparin;

2003
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
    JAMA, 2004, Jul-07, Volume: 292, Issue:1

    Topics: Aged; Angina Pectoris; Aspirin; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans

2004
The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
    Coronary artery disease, 2004, Volume: 15, Issue:6

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; C

2004
Variable extent of clopidogrel responsiveness in patients after coronary stenting.
    Thrombosis and haemostasis, 2004, Volume: 92, Issue:6

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Corona

2004
Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug.
    Journal of the American College of Cardiology, 2005, Aug-16, Volume: 46, Issue:4

    Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel;

2005
Impact of heparin neutralization by protamine on restenosis after coronary stent implantation.
    International journal of cardiology, 2005, Oct-20, Volume: 105, Issue:1

    Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Reste

2005
Postoperative treatment with low molecular weight heparin after right heart assist for coronary artery bypass grafting.
    Scandinavian cardiovascular journal : SCJ, 2005, Volume: 39, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Antifibrinolytic Agents; Aspirin; C

2005
[Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
    Zhonghua yi xue za zhi, 2006, Feb-28, Volume: 86, Issue:8

    Topics: Adenomatous Polyposis Coli; Adolescent; Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-

2006
Serial angiography in patients with acute coronary syndromes: effect of antithrombotic therapy on angiographic lesion severity.
    Heart, lung & circulation, 2006, Volume: 15, Issue:6

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Steno

2006
Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR).
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:2

    Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Artery Disease; Death; Drug Resistance; Female

2007
Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.
    The American journal of cardiology, 1984, Dec-01, Volume: 54, Issue:10

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Animals; Antic

1984
Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.
    Circulation, 1984, Volume: 69, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coumarins; Follow-Up Studies; Humans; M

1984
Dipyridamole: a critical evaluation.
    Drug intelligence & clinical pharmacy, 1984, Volume: 18, Issue:11

    Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro

1984
Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Circulation, 1980, Volume: 62, Issue:6 Pt 2

    Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials a

1980
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
    The New England journal of medicine, 1981, Apr-23, Volume: 304, Issue:17

    Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Arteries; Aspirin; Clinical Trials as Topic; Coron

1981
Exercise-induced angina provoked by aspirin administration in patients with variant angina.
    The American journal of cardiology, 1981, Volume: 47, Issue:6

    Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Coronary Angiography; Electrocardio

1981
Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin.
    Journal of the American College of Cardiology, 1994, Volume: 24, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Angina Pectoris; Aspirin; Cardiac Pacing,

1994
The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
    Coronary artery disease, 1994, Volume: 5, Issue:2

    Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Hu

1994
Antiplatelet therapy--Part I.
    The Western journal of medicine, 1993, Volume: 158, Issue:4

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cardiovascular Diseases; Coronary Artery Bypass; Coronar

1993
Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?
    European heart journal, 1996, Volume: 17, Issue:9

    Topics: Adult; Aged; Analysis of Variance; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Diseas

1996
Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs AC
    Journal of the American College of Cardiology, 1997, Volume: 29, Issue:7

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Calcium Chann

1997
Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA.
    European heart journal, 1998, Volume: 19, Issue:1

    Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Female; Humans; Male; Middle

1998
Enhanced onset of platelet inhibition with a loading dose of ticlopidine in ASA-treated stable coronary patients.
    International journal of cardiology, 1998, Apr-01, Volume: 64, Issue:2

    Topics: Angina Pectoris; Aspirin; Blood Platelets; Female; Humans; Male; Middle Aged; Platelet Aggregation I

1998
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
    Lancet (London, England), 1998, Aug-29, Volume: 352, Issue:9129

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspi

1998
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
    Circulation, 1999, Aug-24, Volume: 100, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein;

1999
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
    Circulation, 1999, Aug-24, Volume: 100, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein;

1999
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
    Circulation, 1999, Aug-24, Volume: 100, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein;

1999
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin.
    Circulation, 1999, Aug-24, Volume: 100, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; C-Reactive Protein;

1999
Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting.
    Angiology, 2000, Volume: 51, Issue:4

    Topics: Acenocoumarol; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coron

2000
Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
    Thrombosis research, 2000, May-15, Volume: 98, Issue:4

    Topics: Aged; alpha-2-Antiplasmin; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Antithro

2000
[Acetylsalicylic acid effects on pain sensitivity to myocardial ischemia and skin sensitivity in patients with angina pectoris].
    Terapevticheskii arkhiv, 2000, Volume: 72, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Aspirin; Chest Pain; Double-Blind Method; Electric Stimulation; Electr

2000
Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin.
    American heart journal, 2000, Volume: 140, Issue:1

    Topics: Acute Disease; Angina Pectoris; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Fema

2000
Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes.
    Clinical cardiology, 2000, Volume: 23, Issue:9

    Topics: Analysis of Variance; Angina Pectoris; Aspirin; Cross-Over Studies; Female; Humans; Lysine; Male; Mi

2000
Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectoris.
    The American journal of cardiology, 2000, Mar-01, Volume: 85, Issue:5

    Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antithrombin III; Aspirin; Athere

2000
Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
    International journal of clinical practice, 2001, Volume: 55, Issue:3

    Topics: Angina Pectoris; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Longitudinal Studies; My

2001
[Does early high dosage dipyridamole in prevention of secondary stroke induce cardiac events?].
    Zeitschrift fur Kardiologie, 2001, Volume: 90, Issue:5

    Topics: Administration, Oral; Angina Pectoris; Aspirin; Cause of Death; Cerebral Infarction; Delayed-Action

2001
Antithrombotic treatment and the incidence of angina pectoris.
    Archives of internal medicine, 2002, Apr-22, Volume: 162, Issue:8

    Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Cohort Studies; Coronary Disease; Double-Blind Metho

2002
Comparison of antiplatelet effect of loading dose of clopidogrel versus abciximab during coronary intervention.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2002, Volume: 13, Issue:4

    Topics: Abciximab; Adenosine Diphosphate; Aged; Aged, 80 and over; Angina Pectoris; Antibodies, Monoclonal;

2002
Effect of aspirin on exercise-induced angina.
    Clinical pharmacology and therapeutics, 1978, Volume: 23, Issue:5

    Topics: Adult; Angina Pectoris; Aspirin; Blood Cell Count; Blood Platelets; Clinical Trials as Topic; Double

1978
Aspirin therapy in angina pectoris: effects on platelet aggregation, exercise tolerance, and electrocardiographic manifestations of ischemia.
    American heart journal, 1976, Volume: 92, Issue:1

    Topics: Adult; Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Disease; Female; Heart Function

1976
Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.
    Lancet (London, England), 1992, Dec-12, Volume: 340, Issue:8833

    Topics: Aged; Angina Pectoris; Aspirin; Double-Blind Method; Female; Hemorrhage; Humans; Male; Myocardial In

1992
The current role of platelet-active drugs in ischaemic heart disease.
    Drugs, 1991, Volume: 41, Issue:5

    Topics: Angina Pectoris; Aspirin; Coronary Disease; Humans; Myocardial Infarction; Platelet Aggregation Inhi

1991
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study.
    American heart journal, 1991, Volume: 122, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Coronary Artery Disease; Co

1991
Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
    Lancet (London, England), 1990, Mar-17, Volume: 335, Issue:8690

    Topics: Administration, Oral; Aged; Analysis of Variance; Angina Pectoris; Angina, Unstable; Aspirin; Double

1990
Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
    Annals of internal medicine, 1991, May-15, Volume: 114, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; beta Carotene; Cardiovascular Diseases; Ca

1991
Ticlopidine in unstable angina. A more expensive aspirin?
    Circulation, 1990, Volume: 82, Issue:1

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Cost-Benefit Analysis; Cycloox

1990
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.
    Circulation, 1990, Volume: 82, Issue:2

    Topics: Aged; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Cardiac Catheterization; Coronary Ang

1990
Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
    The American journal of cardiology, 1990, Dec-01, Volume: 66, Issue:19

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Artery

1990
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians.
    The American journal of medicine, 1990, Volume: 89, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Double-Blind Method; Follow-Up Studies; Hu

1990
Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina.
    Thrombosis and haemostasis, 1990, Apr-12, Volume: 63, Issue:2

    Topics: Adolescent; Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coron

1990
Unstable angina or non-Q wave infarction despite long-term aspirin: response to thrombolytic therapy with implications on mechanisms.
    American heart journal, 1990, Volume: 120, Issue:2

    Topics: Aged; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Biomechanical Phenomena; Cerebral Hem

1990
Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Circulation, 1990, Volume: 81, Issue:1 Suppl

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Diltiazem; Drug Therapy, Combination; Electrocardiograph

1990
Restoration of flow in acute coronary obstructive syndromes: consequences of different management strategies.
    The Canadian journal of cardiology, 1989, Volume: 5, Issue:3

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Circulation; Humans;

1989
Comparative study of heparin and antiplatelets in treatment of preinfarction angina.
    Cardiologia (Rome, Italy), 1989, Volume: 34, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Dipyridamole; Dru

1989
[Do thrombocyte aggregation inhibitors modify silent episodes of unstable angina pectoris in combined anti-angina therapy?].
    Zeitschrift fur Kardiologie, 1989, Volume: 78 Suppl 2

    Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Coronary Circulation; Diltiazem; Drug Therapy, Com

1989
Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
    The American journal of cardiology, 1989, Oct-15, Volume: 64, Issue:14

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Coronary Angiography; Drug Therapy, Combination; Electro

1989
Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study.
    The New England journal of medicine, 1987, Apr-16, Volume: 316, Issue:16

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Clinical Trial

1987
Platelets and antiplatelet therapy in ischemic heart disease.
    Current problems in cardiology, 1986, Volume: 11, Issue:2

    Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a

1986
Long term clinical outcome of coronary surgery and assessment of the benefit obtained with postoperative aspirin and dipyridamole.
    British heart journal, 1988, Volume: 60, Issue:2

    Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Follow-Up

1988
Aspirin, heparin, or both to treat acute unstable angina.
    The New England journal of medicine, 1988, Oct-27, Volume: 319, Issue:17

    Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Double-Blind Me

1988
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cardiovascular clinics, 1987, Volume: 18, Issue:1

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Arte

1987
Aspirin to prevent myocardial infarction and death.
    The Medical letter on drugs and therapeutics, 1986, Mar-14, Volume: 28, Issue:709

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Female; Humans; Male; Myocardi

1986
Effectiveness of anticoagulants.
    Seminars in thrombosis and hemostasis, 1986, Volume: 12, Issue:1

    Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Blood

1986
A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Agents and actions. Supplements, 1986, Volume: 20

    Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro

1986
Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
    Circulation, 1985, Volume: 72, Issue:1

    Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Di

1985
Clinical aspects of antiplatelet therapy.
    Seminars in hematology, 1985, Volume: 22, Issue:2

    Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal

1985
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.
    The New England journal of medicine, 1985, Nov-28, Volume: 313, Issue:22

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Ther

1985
Unstable angina: status of aspirin and other forms of therapy.
    Circulation, 1985, Volume: 72, Issue:6 Pt 2

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Double

1985
[Therapeutic prospects and prostaglandins in vascular pathology].
    Archives des maladies du coeur et des vaisseaux, 1985, Volume: 78 Spec No

    Topics: Angina Pectoris; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteritis; Aspirin;

1985
[Prevention of postoperative thrombo-embolism with acetylsalicyclic acid (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1974, Mar-22, Volume: 99, Issue:12

    Topics: Age Factors; Angina Pectoris; Aspirin; Body Weight; Diabetes Complications; Female; Follow-Up Studie

1974

Other Studies

189 other studies available for aspirin and Angor Pectoris

ArticleYear
Recommendations on the Clinical Use of Compound Danshen Dripping Pills.
    Chinese medical journal, 2017, Apr-20, Volume: 130, Issue:8

    Topics: Angina Pectoris; Aspirin; Camphanes; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diabetic Neph

2017
Clinical characteristics and outcomes of patients with coronary artery spasm who initially presented with acute myocardial infarction.
    Coronary artery disease, 2018, Volume: 29, Issue:1

    Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Dise

2018
Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy.
    Journal of cardiology, 2018, Volume: 72, Issue:1

    Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Administratio

2018
The Prognostic Value of Combinations of Genetic Polymorphisms in the ITGB3, ITGA2, and CYP2C19*2 Genes in Predicting Cardiovascular Outcomes After Coronary Bypass Grafting.
    Genetic testing and molecular biomarkers, 2018, Volume: 22, Issue:4

    Topics: Aged; Alleles; Angina Pectoris; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Byp

2018
Coronary artery fistula with associated Takotsubo cardiomyopathy: a case report.
    Journal of medical case reports, 2018, Mar-30, Volume: 12, Issue:1

    Topics: Angina Pectoris; Anti-Arrhythmia Agents; Aspirin; Cardiac Catheterization; Catecholamines; Chest Pai

2018
Impact of Depressive Disorder on Access and Quality of Care in Veterans With Prevalent Cardiovascular Disease.
    The American journal of cardiology, 2018, 06-15, Volume: 121, Issue:12

    Topics: Age Distribution; Aged; Angina Pectoris; Antihypertensive Agents; Aspirin; Cardiovascular Diseases;

2018
Aspirin in Primary Prevention of Myocardial Infarction/Angina and Stroke in Hypertensive Patients.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Cardiovascular Diseases; Cross-Sectional S

2018
[The Pathways to Increase the Efficacy of Drug Therapy in Patients with Ischemic Heart Disease after Coronary Artery Bypass Grafting].
    Kardiologiia, 2019, Jun-25, Volume: 59, Issue:6

    Topics: Aged; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus,

2019
[Assessment of clinical and antiaggregation efficacy of generic clopidogrel 'Egithromb' in roentgenosurgical practice].
    Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2013, Volume: 19, Issue:1

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronar

2013
64-MDCT can depict the thrombi expanded from the left lower pulmonary vein to the left atrium in the patient with angina pectoris.
    BMJ case reports, 2013, Apr-03, Volume: 2013

    Topics: Aged; Angina Pectoris; Aspirin; Coronary Thrombosis; Diagnosis, Differential; Echocardiography; Hear

2013
Aspirin resistance in Thai patients with chronic stable angina.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2013, Volume: 96 Suppl 2

    Topics: Aged; Angina Pectoris; Asian People; Aspirin; Chronic Disease; Drug Resistance; Female; Humans; Male

2013
Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:8

    Topics: Aged; Alleles; Angina Pectoris; Aryldialkylphosphatase; Aspirin; Clopidogrel; Cohort Studies; Corona

2014
[Perioperative complications of transurethral resection of bladder tumor in patients receiving antithrombotic therapy].
    Hinyokika kiyo. Acta urologica Japonica, 2014, Volume: 60, Issue:11

    Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Cystectomy; Female; Fibrinolytic Agents; Hemorrha

2014
Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents.
    Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:1

    Topics: Activation, Metabolic; Aged; Alleles; Angina Pectoris; Angioscopy; Aspirin; Clopidogrel; Coronary An

2015
Cytochrome P450 CYP 2C19*2 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Activation, Metabolic; Acute Coronary Syndrome; Aged; Alleles; Angina Pectoris; Aspirin; Clopidogrel

2015
Does high serum uric acid level cause aspirin resistance?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:4

    Topics: Aged; Angina Pectoris; Aspirin; Biomarkers; Blood Cell Count; Blood Glucose; C-Reactive Protein; Cor

2016
Chronic Kidney Disease and Health Status Outcomes Following Acute Myocardial Infarction.
    Journal of the American Heart Association, 2016, 05-23, Volume: 5, Issue:5

    Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Case-Control Studies; Coho

2016
A 55-Year-Old Woman With Pulmonary Hypertension, Worsening Dyspnea, and Chest Pain.
    Chest, 2014, Volume: 145, Issue:3

    Topics: Angina Pectoris; Aspirin; Clopidogrel; Compartment Syndromes; Coronary Vessels; Diagnosis, Different

2014
Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
    The American journal of cardiology, 2008, Jun-15, Volume: 101, Issue:12

    Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Confidence Intervals; Elective Surgical Procedures; Fem

2008
Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance.
    Journal of Korean medical science, 2008, Volume: 23, Issue:3

    Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Resista

2008
Lack of early augmentation of platelet reactivity after coronary intervention in patients treated with bivalirudin.
    Journal of thrombosis and thrombolysis, 2009, Volume: 28, Issue:1

    Topics: Adenosine Diphosphate; Angina Pectoris; Anticoagulants; Aspirin; Cardiac Catheterization; Clopidogre

2009
Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    The Journal of invasive cardiology, 2008, Volume: 20, Issue:10

    Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coro

2008
Transient left ventricular apical ballooning complicated by a mural thrombus and outflow tract obstruction in a patient with pheochromocytoma.
    Texas Heart Institute journal, 2008, Volume: 35, Issue:4

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Angina Pectoris; Anticoagulants; Aspirin; Che

2008
Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy.
    Journal of cardiology, 2009, Volume: 54, Issue:1

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Female; Follow-Up Studies; Gastric M

2009
Significance of platelet volume indices and platelet count in ischaemic heart disease.
    Journal of clinical pathology, 2009, Volume: 62, Issue:9

    Topics: Acute Coronary Syndrome; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cell Size; Female;

2009
Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication.
    Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:1

    Topics: Acute Coronary Syndrome; Angina Pectoris; Aspirin; Biomarkers; Blood Platelets; Clopidogrel; Coronar

2010
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire international, 2009, Volume: 18, Issue:104

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clini

2009
Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study.
    Circulation. Cardiovascular quality and outcomes, 2009, Volume: 2, Issue:2

    Topics: Aged; Angina Pectoris; Aspirin; Cardiovascular Diseases; Death, Sudden, Cardiac; Dose-Response Relat

2009
Influence of sex on the out-of-hospital management of chest pain.
    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2010, Volume: 17, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Aspirin; Chest Pain; Emergency Medical Services; Fem

2010
Subacute coronary stent thrombosis in a patient with angina treated with double antiplatelet drugs for six days.
    Chinese medical journal, 2009, Oct-05, Volume: 122, Issue:19

    Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; D

2009
Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    The American journal of cardiology, 2010, Feb-01, Volume: 105, Issue:3

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Platelets; Clopido

2010
Long-term clinical course of patients with isolated myocardial bridge.
    Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:3

    Topics: Aged; Angina Pectoris; Aspirin; Coronary Angiography; Coronary Vasospasm; Female; Follow-Up Studies;

2010
Understanding angina. When chest pain strikes, it's essential to know what action to take.
    The Johns Hopkins medical letter health after 50, 2010, Volume: 22, Issue:2

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Chest Pain; Combined Modality Therapy; Cor

2010
Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Gender medicine, 2010, Volume: 7, Issue:6

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Aspirin; Blood Gluco

2010
[Current status of medical therapy of chronic stable angina pectoris in mainland of China: the second survey].
    Zhonghua xin xue guan bing za zhi, 2010, Volume: 38, Issue:12

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angiotensin Receptor A

2010
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel.
    Journal of thrombosis and thrombolysis, 2011, Volume: 32, Issue:1

    Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Glucose; Blood Platelets; Clopidogrel; Diab

2011
Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications.
    Urology, 2011, Volume: 78, Issue:6

    Topics: Aged; Angina Pectoris; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Blood Transfusion; Humans; Isc

2011
Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors.
    Saudi medical journal, 2012, Volume: 33, Issue:1

    Topics: Aged; Angina Pectoris; Aspirin; Drug Resistance; Female; Humans; Male; Middle Aged; Risk Factors

2012
Microtrauma-induced recurrent hyphema and secondary glaucoma associated with chronic acetylsalicylic acid use.
    International ophthalmology, 2012, Volume: 32, Issue:1

    Topics: Administration, Oral; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Diagnosis, Different

2012
[Aspirin].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 7

    Topics: Angina Pectoris; Aspirin; Coronary Disease; Female; Humans; Male; Myocardial Infarction

2011
Long-term successful percutaneous coronary intervention in factor VII deficiency.
    The Journal of invasive cardiology, 2012, Volume: 24, Issue:6

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Diabetes M

2012
The power of statistics.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 2002, Volume: 52, Issue:482

    Topics: Angina Pectoris; Aspirin; Confidence Intervals; Drug Prescriptions; Health Facility Size; Humans; Ph

2002
How to keep chest pain from cramping your style. If you are one of the millions of Americans for whom chest pain is part of daily life, here are some ABCs for getting it under control.
    Harvard heart letter : from Harvard Medical School, 2002, Volume: 13, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Aspirin; Chest Pain; Diet; Exercise; Fema

2002
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate.
    Thrombosis research, 2002, Jul-15, Volume: 107, Issue:1-2

    Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Aspirin; Blood Platelets; Case-Control Studies; Corona

2002
Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    American heart journal, 2003, Volume: 145, Issue:2

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biomarkers; C-Reacti

2003
Clopidogrel and percutaneous coronary interventions.
    JAMA, 2003, Apr-16, Volume: 289, Issue:15

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Drug Administration Schedule;

2003
Effectiveness of multifaceted implementation of guidelines in primary care.
    Journal of health services research & policy, 2003, Volume: 8, Issue:3

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Asthma; Bronchodilator Agents; Drug Utilizati

2003
[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
    Kardiologiia, 2003, Volume: 43, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Angiotens

2003
[CHEST PSEUDOANGINA DUE TO COSTAL CHONDRODYNIA. TIETZE'S SYNDROME].
    Prensa medica argentina, 1963, Nov-15, Volume: 50

    Topics: Angina Pectoris; Aspirin; Cartilage; Diagnosis, Differential; Humans; Ribs; Thorax; Tietze's Syndrom

1963
Is preinfarction angina associated with better outcome after myocardial infarction?
    Kardiologia polska, 2003, Volume: 58, Issue:6

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-I

2003
Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
    Thrombosis research, 2003, Volume: 111, Issue:3

    Topics: Abciximab; Adenosine Diphosphate; Aged; Angina Pectoris; Antibodies, Monoclonal; Aspirin; Bleeding T

2003
Catheter based intracoronary brachytherapy leads to increased platelet activation.
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:2

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Blood Platelets; Brachythe

2004
Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD.
    Circulation, 2004, Jan-20, Volume: 109, Issue:2

    Topics: Acetanilides; Angina Pectoris; Aspirin; Clinical Trials as Topic; Delayed-Action Preparations; Drug

2004
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris.
    Circulation, 2004, Apr-13, Volume: 109, Issue:14

    Topics: Aged; Angina Pectoris; Anticoagulants; Aspirin; Biomarkers; Blood Proteins; C-Reactive Protein; Coro

2004
Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study.
    American heart journal, 2004, Volume: 147, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin;

2004
Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes.
    Circulation, 2004, Sep-21, Volume: 110, Issue:12

    Topics: Abciximab; Acute Disease; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclo

2004
Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis.
    Journal of the American College of Cardiology, 2005, Feb-01, Volume: 45, Issue:3

    Topics: Aged; Angina Pectoris; Aspirin; Coronary Artery Disease; Female; Fibrinolytic Agents; Graft Occlusio

2005
Myocardial infarction after aspirin treatment, and Kounis syndrome.
    Journal of the Royal Society of Medicine, 2005, Volume: 98, Issue:6

    Topics: Angina Pectoris; Aspirin; Coronary Vasospasm; Fibrinolytic Agents; Humans; Mast Cells; Myocardial In

2005
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
    American heart journal, 2005, Volume: 150, Issue:2

    Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Mono

2005
Should aspirin be discontinued before coronary artery bypass surgery?
    Circulation, 2005, Aug-16, Volume: 112, Issue:7

    Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox

2005
Should aspirin be discontinued before coronary artery bypass surgery?
    Circulation, 2005, Aug-16, Volume: 112, Issue:7

    Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox

2005
Should aspirin be discontinued before coronary artery bypass surgery?
    Circulation, 2005, Aug-16, Volume: 112, Issue:7

    Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox

2005
Should aspirin be discontinued before coronary artery bypass surgery?
    Circulation, 2005, Aug-16, Volume: 112, Issue:7

    Topics: Aged; Angina Pectoris; Aspirin; Blood Transfusion; Coronary Artery Bypass; Coronary Disease; Cycloox

2005
Borderline coronary lesions may lead to serious coronary events--long-term outcome in 65 conservatively treated patients.
    Kardiologia polska, 2005, Volume: 63, Issue:7

    Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Coronary

2005
Detection of aspirin resistance by PFA-100: prevalence and aspirin compliance in patients with chronic stable angina.
    Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Case-Control Studies; Female; Humans; Male

2005
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
    International journal of cardiology, 2006, Mar-22, Volume: 108, Issue:1

    Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combinatio

2006
[Thrombosis of a coronary stent after discontinuing treatment with clopidogrel].
    Nederlands tijdschrift voor geneeskunde, 2006, Apr-15, Volume: 150, Issue:15

    Topics: Adult; Aged; Angina Pectoris; Aspirin; Clopidogrel; Female; Humans; Male; Myocardial Infarction; Pla

2006
Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.
    International journal of clinical practice, 2006, Volume: 60, Issue:7

    Topics: Angina Pectoris; Aspirin; Chronic Disease; Coronary Stenosis; Drug Therapy, Combination; Humans; Mal

2006
Softening the blow.
    Harvard heart letter : from Harvard Medical School, 2006, Volume: 16, Issue:11

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Car

2006
Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation.
    Journal of the American College of Cardiology, 2006, Oct-17, Volume: 48, Issue:8

    Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Arteries; Aspirin; beta-Thromboglobulin; Blood Pla

2006
Hymenoptera sting-induced Kounis syndrome: effects of aspirin and beta-blocker administration.
    International journal of cardiology, 2007, Sep-14, Volume: 121, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Animals; Anti-Inflammatory Agents, Non-Steroidal

2007
[Acute myocardial infarction after discontinuing aspirin two years after implantation of a drug-eluting coronary stent].
    Deutsche medizinische Wochenschrift (1946), 2007, Feb-02, Volume: 132, Issue:5

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Contraindications; Coronary Angiography; C

2007
Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
    International journal of cardiology, 2008, Jan-11, Volume: 123, Issue:2

    Topics: Angina Pectoris; Aspirin; Chronic Disease; Clopidogrel; Humans; Platelet Aggregation; Platelet Aggre

2008
Increased incidence of stent thrombosis in patients with cocaine use.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jun-01, Volume: 69, Issue:7

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cocaine-Related Disorders; Co

2007
[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre].
    Archives des maladies du coeur et des vaisseaux, 2007, Volume: 100, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronar

2007
[Stable angina pectoris can be treated successfully by drugs alone--pro].
    Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:39

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cal

2007
Evaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columns.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2007, Volume: 13, Issue:4

    Topics: Aged; Angina Pectoris; Aspirin; Blood Platelets; Case-Control Studies; Collagen; Female; Hemorheolog

2007
Myocardial infarcts in a patient with a single right sided coronary ostium and interarterial course of the circumflex artery: the role of multi-modality imaging.
    International journal of cardiology, 2009, Feb-06, Volume: 132, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticholesteremic Agents; Antihypertensive Agents; Asp

2009
The editor's roundtable: chronic stable angina pectoris.
    The American journal of cardiology, 2007, Dec-01, Volume: 100, Issue:11

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Calcium Chann

2007
[Aspirin and endoscopy].
    Harefuah, 2008, Volume: 147, Issue:1

    Topics: Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colonoscopy; Drug Administr

2008
[Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations].
    Ugeskrift for laeger, 2008, Mar-31, Volume: 170, Issue:14

    Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Aspirin;

2008
Thioredoxin in coronary culprit lesions: possible relationship to oxidative stress and intraplaque hemorrhage.
    Atherosclerosis, 2008, Volume: 201, Issue:2

    Topics: Aged; Angina Pectoris; Aspirin; Female; Gene Expression Regulation; Glycophorins; Hemorrhage; Humans

2008
[Coronary artery bypass grafting for simultaneous subacute stent thrombosis after sirolimus-eluting stent implantation].
    Kyobu geka. The Japanese journal of thoracic surgery, 2008, Volume: 61, Issue:5

    Topics: Aged, 80 and over; Angina Pectoris; Aspirin; Coronary Artery Bypass; Coronary Restenosis; Coronary T

2008
[Effects of medical therapy on long-term survival in ischemic heart disease].
    Minerva cardioangiologica, 1984, Volume: 32, Issue:12

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Anticoagulants; Aspirin; Calcium Channel Blocker

1984
Serial angiographic evidence of rapid resolution of coronary artery stenosis.
    Chest, 1983, Volume: 84, Issue:3

    Topics: Angina Pectoris; Angiography; Angioplasty, Balloon; Aspirin; Coronary Disease; Dipyridamole; Humans;

1983
Unstable angina in a patient with mucocutaneous lymph node syndrome.
    Japanese heart journal, 1984, Volume: 25, Issue:4

    Topics: Aneurysm; Angina Pectoris; Angina, Unstable; Aspirin; Child; Coronary Angiography; Coronary Artery B

1984
Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms.
    The American journal of cardiology, 1984, Dec-01, Volume: 54, Issue:10

    Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Aorta; Aspirin; Blood Pres

1984
Role of thromboxanes in vasotonic versus vaso-occlusive angina.
    Archives des maladies du coeur et des vaisseaux, 1983, Volume: 76 Spec No

    Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Ca

1983
The role of the platelets.
    Zeitschrift fur Kardiologie, 1984, Volume: 73 Suppl 2

    Topics: Adenosine Diphosphate; Angina Pectoris; Animals; Aspirin; Blood Platelets; Coronary Disease; Hemodyn

1984
Aspirin and the risk of myocardial infarction.
    The New England journal of medicine, 1984, Jan-12, Volume: 310, Issue:2

    Topics: Angina Pectoris; Aspirin; Humans; Male; Myocardial Infarction

1984
Aspirin in the prevention of myocardial infarction. Current status.
    Drugs, 1984, Volume: 28, Issue:1

    Topics: Angina Pectoris; Aspirin; Cerebrovascular Disorders; Fibrinolytic Agents; Humans; Myocardial Infarct

1984
Randomized surgical clinical trials for treatment of coronary artery disease.
    Controlled clinical trials, 1982, Volume: 3, Issue:3

    Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Europe

1982
Medical and surgical treatment of angina.
    Journal of the South Carolina Medical Association (1975), 1981, Volume: 77, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Female; Humans; Male; Middle Aged; Nitroglyc

1981
[Problems of the operated patient and suggestions for their treatment].
    Giornale italiano di cardiologia, 1982, Volume: 12, Issue:3

    Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As

1982
Recent concepts on platelet function and dietary lipids in coronary thrombosis, vasospasm and angina.
    Herz, 1980, Volume: 5, Issue:1

    Topics: Angina Pectoris; Arachidonic Acids; Aspirin; Constriction, Pathologic; Coronary Disease; Dietary Fat

1980
Humoral heartache -- do platelets have a role?
    The New England journal of medicine, 1981, Apr-23, Volume: 304, Issue:17

    Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Aspirin; Blood Platelets; Coronary Circulation;

1981
[Electron microscopic, histochemical and functional assessment of the effect of aspirin on the thrombocytes of healthy persons and ischemic heart disease patients].
    Kardiologiia, 1982, Volume: 22, Issue:2

    Topics: Adult; Angina Pectoris; Aspirin; Blood Platelets; Coronary Disease; Histocytochemistry; Humans; Micr

1982
[The treatment of chronic ischemic heart disease with acidum acetylsalicylicum in older patients (author's transl)].
    Zeitschrift fur Alternsforschung, 1980, Volume: 35, Issue:6

    Topics: Aged; Angina Pectoris; Aspirin; Cholesterol; Coronary Disease; Double-Blind Method; Humans; Male; Ri

1980
[Spontaneous and repetitive angor pectoris. Temporary mitral insufficiency. Cessation of crisis under aspirin. Decline of fifteen months. Physiopathological and therapeutic considerations (author's transl)].
    Annales de cardiologie et d'angeiologie, 1981, Volume: 30, Issue:5

    Topics: Aged; Angina Pectoris; Aspirin; Follow-Up Studies; Humans; Male; Mitral Valve Insufficiency

1981
Platelet activation during exercise-induced myocardial ischemia.
    The New England journal of medicine, 1980, Jan-24, Volume: 302, Issue:4

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Aspirin; Blood Coagulation Factors; Blood Platelets; Child

1980
Platelets and ischemic heart disease.
    The New England journal of medicine, 1980, Jan-24, Volume: 302, Issue:4

    Topics: Angina Pectoris; Aspirin; Blood Platelets; Coronary Disease; Death, Sudden; Exercise Test; Humans; M

1980
Platelet function studies in coronary artery disease. VII. Effect of aspirin and tachycardia stress on aortic and coronary venous blood.
    The American journal of cardiology, 1980, Volume: 45, Issue:5

    Topics: Adult; Angina Pectoris; Aorta; Aspirin; Coronary Disease; Coronary Vessels; Humans; Middle Aged; Pla

1980
Thromboxane receptor antagonist BMS-180291, but not aspirin, reduces the severity of pacing-induced ischemia in dogs.
    Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:3

    Topics: Angina Pectoris; Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Pacing, Artifici

1994
[Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
    Cardiologia (Rome, Italy), 1994, Volume: 39, Issue:12 Suppl 1

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Humans; Myocardial

1994
[Use of aspirin in coronary disease].
    Presse medicale (Paris, France : 1983), 1995, Jun-03, Volume: 24, Issue:20

    Topics: Angina Pectoris; Anticoagulants; Aspirin; Coronary Disease; Dose-Response Relationship, Drug; Humans

1995
Prescription of regular aspirin in patients with chest pain referred to a cardiology outpatient clinic.
    BMJ (Clinical research ed.), 1995, Mar-25, Volume: 310, Issue:6982

    Topics: Angina Pectoris; Aspirin; Cardiology Service, Hospital; Chest Pain; Drug Utilization; Family Practic

1995
Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation.
    American heart journal, 1995, Volume: 129, Issue:5

    Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Dose-Response Relationship, Drug;

1995
[Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent].
    Zeitschrift fur Kardiologie, 1995, Volume: 84, Issue:1

    Topics: Aged; Angina Pectoris; Anticoagulants; Antithrombin III; Aspirin; Blood Coagulation Factors; Female;

1995
Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1994, Volume: 5, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Anticoagulants; Antithrombin III; Aspirin; Female; Heparin; Humans; Ki

1994
[Sliding indications for balloon angioplasty].
    Nederlands tijdschrift voor geneeskunde, 1994, Jul-23, Volume: 138, Issue:30

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspi

1994
[Drug treatment following an infarction].
    Revue medicale de la Suisse romande, 1994, Volume: 114, Issue:8

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anticoagulan

1994
Impact of treatment with acetylsalicylic acid on the proaggregatory effects of adrenaline in vitro in patients with stable angina pectoris: influence of the anticoagulant.
    Clinical science (London, England : 1979), 1993, Volume: 85, Issue:5

    Topics: Adenosine Diphosphate; Angina Pectoris; Aspirin; Citrates; Drug Synergism; Epinephrine; Female; Hiru

1993
Oral verapamil inhibits platelet thrombus formation in humans.
    Circulation, 1994, Volume: 89, Issue:2

    Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Blood Pressure; Delaye

1994
Clinical and angiographic determinants of initial percutaneous transluminal coronary angioplasty success.
    Angiology, 1993, Volume: 44, Issue:9

    Topics: Aged; Angina Pectoris; Angiography; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass;

1993
Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.
    Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:8

    Topics: Adult; Aged; Angina Pectoris; Antithrombins; Aspirin; Cholesterol; Female; Humans; Hypercholesterole

1996
The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1995, Volume: 6, Issue:8

    Topics: Angina Pectoris; Aspirin; Fibrin; Humans; Time Factors; Tissue Plasminogen Activator

1995
Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium.
    Thrombosis research, 1996, Sep-01, Volume: 83, Issue:5

    Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Aspirin; Cell Adhesion; Coronary Disease; Dose-

1996
N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:3

    Topics: Acetylcysteine; Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Drug Synergism; Female; Free

1996
A prospective study of anger and coronary heart disease. The Normative Aging Study.
    Circulation, 1996, Nov-01, Volume: 94, Issue:9

    Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Anger; Angina Pecto

1996
Current approaches to stable angina.
    The Practitioner, 1996, Volume: 240, Issue:1568

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Aspirin; Humans; Hypolipidemic Agents; Middle Ag

1996
Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls.
    European heart journal, 1997, Volume: 18, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Arousal; Aspirin; beta-Thromboglobulin; Exercise Test; Female; Hemodyn

1997
Predictors of hospital readmission two years after coronary artery bypass grafting.
    Heart (British Cardiac Society), 1997, Volume: 77, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Aspirin; Coronary Artery

1997
Stroke recurrence among 30 days survivors of ischemic stroke in a prospective community-based study.
    Neurological research, 1997, Volume: 19, Issue:4

    Topics: Aged; Angina Pectoris; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Cohort Studies; Female; F

1997
ASHP therapeutic position statement on the use of aspirin for prophylaxis of myocardial infarction.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Sep-01, Volume: 54, Issue:17

    Topics: Aged; Angina Pectoris; Aspirin; Female; Humans; Male; Middle Aged; Myocardial Infarction; Patient Se

1997
Clinical and angiographic outcome of Micro Stent II implantation in native coronary arteries.
    The American journal of cardiology, 1998, Jan-15, Volume: 81, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Blood Vessel Prosthesis Implantation; Coro

1998
Emergency coronary artery bypass grafting (CABG) after failed coronary artery intervention--caution regarding the combined use of aspirin, ticlopidine and abciximab.
    Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:4

    Topics: Abciximab; Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin;

1998
Aspirin improves organic nitrate treatment for angina pectoris. Calcium channel antagonists do not decrease plasma inorganic nitrate levels.
    International journal of cardiology, 1998, Sep-01, Volume: 66, Issue:1

    Topics: Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Interactions; Humans; Isosorbide Dinitrate

1998
Aspirin administration for cardiac-related acute chest pain/angina: increased use in Medicare patients.
    Southern medical journal, 1999, Volume: 92, Issue:1

    Topics: Acute Disease; Aged; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Critical Pat

1999
The management of stable angina.
    The Health service journal, 1997, Oct-30, Volume: 107, Issue:5577

    Topics: Angina Pectoris; Angioplasty, Balloon; Aspirin; Cardiovascular Agents; Coronary Artery Bypass; Evide

1997
Refining instructional text generation after evaluation.
    Artificial intelligence in medicine, 1999, Volume: 17, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Artificial Intelligence; Aspirin; Atenolol; Decision M

1999
Aspirin and plasma interleukin-6 acute coronary syndromes.
    Cardiovascular research, 1999, Volume: 42, Issue:3

    Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Humans; Interleukin-6

1999
[Ticlopidine-induced cholestasis].
    Schweizerische medizinische Wochenschrift, 1999, Oct-02, Volume: 129, Issue:39

    Topics: Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Chemical and Drug Induced Liver Injury; Cholestas

1999
Women with angina pectoris receive less antiplatelet treatment than men.
    The British journal of general practice : the journal of the Royal College of General Practitioners, 1999, Volume: 49, Issue:441

    Topics: Aged; Angina Pectoris; Aspirin; Family Practice; Female; Humans; Male; Middle Aged; Myocardial Ische

1999
Influence of SIN-1 on platelet Ca2+ handling in patients with suspected coronary artery disease: ex vivo and in vitro studies.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:5

    Topics: Angina Pectoris; Aspirin; Biological Transport; Blood Platelets; Calcium; Calcium Signaling; Catalas

2000
Nonatherosclerotic aneurysm of the left circumflex coronary artery presenting with accelerated angina pectoris: response to medical management--a case report.
    Angiology, 2000, Volume: 51, Issue:7

    Topics: Adrenergic beta-Agonists; Angina Pectoris; Anticoagulants; Aspirin; Coronary Aneurysm; Heparin; Huma

2000
[ELAN study].
    Archives des maladies du coeur et des vaisseaux, 2000, Volume: 93, Issue:3

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Data

2000
[One-year follow-up of a population of patients with angina. Factors influencing mortality and occurrence of cardiovascular events. Results of the ELAN study].
    Archives des maladies du coeur et des vaisseaux, 2000, Volume: 93, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Anti-Infl

2000
Ticlopidine and aspirin fail to suppress the increased platelet aggregability that follows percutaneous coronary interventions.
    Journal of thrombosis and thrombolysis, 2000, Volume: 10, Issue:3

    Topics: Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Blood Coagulation Tests; Coronary Angiography;

2000
Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey.
    Diabetes care, 2001, Volume: 24, Issue:2

    Topics: Adult; Albuminuria; Angina Pectoris; Aspirin; Cardiovascular Diseases; Diabetes Complications; Diabe

2001
[Late stent thrombosis after intracoronary brachytherapy. A case report and review of the literature].
    Zeitschrift fur Kardiologie, 2001, Volume: 90, Issue:2

    Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Brachytherapy; Clinical Trials as Topic; C

2001
Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    The Journal of family practice, 2001, Volume: 50, Issue:7

    Topics: Angina Pectoris; Aspirin; Double-Blind Method; Fibrinolytic Agents; Humans; Multicenter Studies as T

2001
[Spontaneous intraspinal epidural hematoma secondary to use of platelet aggregation inhibitors].
    Deutsche medizinische Wochenschrift (1946), 2001, Aug-03, Volume: 126, Issue:31-32

    Topics: Angina Pectoris; Aspirin; Female; Hematoma, Epidural, Cranial; Humans; Laminectomy; Magnetic Resonan

2001
Guidelines for the management of patients with chronic stable angina: treatment.
    Annals of internal medicine, 2001, Oct-16, Volume: 135, Issue:8 Pt 1

    Topics: Adrenergic beta-Antagonists; Adult; Algorithms; Angina Pectoris; Aspirin; Calcium Channel Blockers;

2001
Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery.
    Journal of the American College of Cardiology, 2001, Nov-01, Volume: 38, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Analysis of Variance; Angina Pectoris; Aspirin; Case-Control Stud

2001
Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study.
    American heart journal, 2001, Volume: 142, Issue:6

    Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Angioplasty,

2001
Natural history of small and medium-sized side branches after coronary stent implantation.
    American heart journal, 2002, Volume: 143, Issue:4

    Topics: Acute Disease; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary An

2002
Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.
    The New England journal of medicine, 2002, Jun-27, Volume: 346, Issue:26

    Topics: Abciximab; Aged; Angina Pectoris; Antibodies, Monoclonal; Aspirin; Biomarkers; Creatinine; Female; H

2002
Platelet function and myocardial injury during percutaneous coronary intervention.
    Journal of thrombosis and thrombolysis, 2002, Volume: 13, Issue:2

    Topics: Aged; Angina Pectoris; Aspirin; Biomarkers; Cardiac Surgical Procedures; Female; Humans; Intraoperat

2002
[Prinzmetal's angina. Considerations on a clinical case].
    Bollettino della Societa italiana di cardiologia, 1977, Volume: 22, Issue:3

    Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina Pectoris, Variant; Aspirin; Electrocardi

1977
The effect of heparin and acetysal on blood platelet functions in coronary sclerosis.
    Folia medica, 1978, Volume: 20, Issue:1

    Topics: Adult; Angina Pectoris; Aspirin; Blood Platelets; Coronary Disease; Heparin; Humans; Myocardial Infa

1978
Antiplatelet agents in coronary disease: are they of prophylactic value?
    Drugs, 1978, Volume: 15, Issue:6

    Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrin

1978
[Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
    Minerva cardioangiologica, 1978, Volume: 26, Issue:6

    Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Coronary Disea

1978
Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study.
    Mayo Clinic proceedings, 1978, Volume: 53, Issue:9

    Topics: Adult; Aged; Angina Pectoris; Arthritis, Rheumatoid; Aspirin; Cerebrovascular Disorders; Coronary Di

1978
[Platelet aggregation before and after exertion in subjects with infarction in the rehabilitation phase].
    Bollettino della Societa italiana di cardiologia, 1978, Volume: 23, Issue:4

    Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Aspirin; Exercise Therapy; Humans; Male; Middle Aged;

1978
Peripheral venous platelet aggregates in patients with unstable angina pectoris and acute myocardial infarction.
    Angiology, 1977, Volume: 28, Issue:10

    Topics: Acute Disease; Adenosine Diphosphate; Adult; Angina Pectoris; Aspirin; Blood Cell Count; Female; Hum

1977
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
    Thrombosis and haemostasis, 1976, Jun-30, Volume: 35, Issue:3

    Topics: Adenosine; Adult; Aged; Angina Pectoris; Apyrase; Arterial Occlusive Diseases; Aspirin; Coronary Dis

1976
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
    Acta clinica Belgica, 1976, Volume: 31, Issue:4

    Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coro

1976
[Therapy of coronary disease].
    Deutsche medizinische Wochenschrift (1946), 1992, Jan-03, Volume: 117, Issue:1

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Clinical Trials as

1992
[The combination of taking acetylsalicylic acid and a complex of physical factors in the rehabilitative treatment of patients with ischemic heart disease].
    Likars'ka sprava, 1992, Issue:2

    Topics: Angina Pectoris; Aspirin; Combined Modality Therapy; Humans; Myocardial Ischemia; Physical Exertion;

1992
[Acute myocardial injury and repeated angina pectoris-like attacks in a young patient with Churg-Strauss syndrome].
    Nihon Kyobu Shikkan Gakkai zasshi, 1991, Volume: 29, Issue:12

    Topics: Adult; Age Factors; Angina Pectoris; Aspirin; Asthma; Churg-Strauss Syndrome; Eosinophilia; Humans;

1991
[Effect of intravenous administration of aspisol on hemostasis and pain syndrome in patients with progressive angina].
    Klinicheskaia meditsina, 1991, Volume: 69, Issue:5

    Topics: Aged; Angina Pectoris; Aspirin; Female; Hemostasis; Humans; Lysine; Male; Middle Aged; Platelet Aggr

1991
[New-onset angina pectoris: clinical aspects, diagnosis, prognosis and treatment tactics].
    Sovetskaia meditsina, 1991, Issue:6

    Topics: Angina Pectoris; Aspirin; Calcium Channel Blockers; Electrocardiography; Exercise Test; Humans; Midd

1991
Early public use of aspirin in the face of probable ischaemic chest pain.
    Lancet (London, England), 1990, Jan-20, Volume: 335, Issue:8682

    Topics: Angina Pectoris; Aspirin; Death, Sudden; Humans; Myocardial Infarction; Time Factors

1990
Coronary angioplasty for medically refractory unstable angina in patients with prior coronary bypass surgery.
    Catheterization and cardiovascular diagnosis, 1990, Volume: 20, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary

1990
Therapeutic interventions which may improve survival in patients with coronary artery disease.
    Acta cardiologica, 1990, Volume: 45, Issue:6

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Aspirin; Coronary Artery Bypass; Cor

1990
[Adhesive activity of blood platelets in patients with stable or unstable angina pectoris and acute myocardial infarct].
    Kardiologiia, 1991, Volume: 31, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Creatine Kinase; Humans; Male; Microscopy,

1991
[Expediency of long-term anti-angina therapy and physical exercises in patients with angina pectoris and a history of myocardial infarction].
    Klinicheskaia meditsina, 1990, Volume: 68, Issue:9

    Topics: Adult; Angina Pectoris; Aspirin; Exercise Therapy; Humans; Male; Middle Aged; Myocardial Infarction;

1990
Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina.
    Cardiovascular research, 1990, Volume: 24, Issue:1

    Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Bleeding Time; Blood Platelets; Chest Pain; Epinep

1990
Defective coronary prostaglandin modulation in anginal patients.
    American heart journal, 1990, Volume: 120, Issue:1

    Topics: Adult; Angina Pectoris; Aspirin; Blood Pressure; Cold Temperature; Coronary Vessels; Female; Humans;

1990
[Unstable stenocardia: various problems of pathogenesis and treatment].
    Kardiologiia, 1989, Volume: 29, Issue:10

    Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Constriction, Pathologic

1989
Aspirin, heparin, or both to treat unstable angina.
    The New England journal of medicine, 1989, Apr-13, Volume: 320, Issue:15

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Heparin; Humans; Myocardial Infarction

1989
[Antiplatelet effects of combined therapy with ticlopidine and low doses of aspirin on patients with ischemic cardiopathy].
    Cardiologia (Rome, Italy), 1989, Volume: 34, Issue:1

    Topics: Aged; Angina Pectoris; Aspirin; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Ag

1989
Aspirin, nifedipine, and cataract.
    Lancet (London, England), 1986, Jul-05, Volume: 2, Issue:8497

    Topics: Angina Pectoris; Aspirin; Cataract; Humans; Nifedipine

1986
[Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Aspirin; Dipyridamole; Drug Therapy, Comb

1986
Unstable angina revisited once more.
    European heart journal, 1986, Volume: 7, Issue:12

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Combi

1986
Management of patients after myocardial infarction.
    Hospital practice (Office ed.), 1987, Apr-15, Volume: 22, Issue:4

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anticoagulants; Aspirin; Cardiac Cat

1987
Use of percutaneous transluminal coronary angioplasty and bypass surgery despite improved medical therapy for unstable angina pectoris.
    The American journal of cardiology, 1988, May-09, Volume: 61, Issue:14

    Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Calci

1988
Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology.
    Circulation, 1989, Volume: 79, Issue:1

    Topics: Aged; Angina Pectoris; Angiography; Aorta; Aspirin; Blood Specimen Collection; Coronary Circulation;

1989
Coronary angioplasty in refractory unstable angina.
    The New England journal of medicine, 1986, Jan-30, Volume: 314, Issue:5

    Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Aspirin; Coronary Vessels; Humans

1986
Aspirin for unstable angina?
    British medical journal (Clinical research ed.), 1986, Jul-05, Volume: 293, Issue:6538

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Humans; Myocardial Infarction; Platelet Aggregation; Pro

1986
[Hemodynamic effects of nitroglycerin following acute inhibition of prostaglandin synthesis].
    Zeitschrift fur Kardiologie, 1986, Volume: 75, Issue:11

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Angina Pectoris; Aspirin; Cyclooxygenase Inhibitors; Dinoprosto

1986
Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina.
    Thrombosis research, 1987, Apr-15, Volume: 46, Issue:2

    Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Arachidonic Acid; Arachidonic Acids; Aspirin; Bloo

1987
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
    British medical journal (Clinical research ed.), 1988, Jan-30, Volume: 296, Issue:6618

    Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinatio

1988
Protective effects of the antianginal agent nicorandil on arachidonate-induced sudden death in rats: comparison with several antianginal agents and cyclooxygenase inhibitors.
    Japanese journal of pharmacology, 1985, Volume: 37, Issue:1

    Topics: Angina Pectoris; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; D

1985
Clinical experience of percutaneous transluminal coronary angioplasty--technique and results.
    Japanese circulation journal, 1985, Volume: 49, Issue:6

    Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease;

1985
[Effect of various drugs on rheological properties of the blood and hemostasis in patients with unstable stenocardia].
    Klinicheskaia meditsina, 1987, Volume: 65, Issue:4

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Blood Viscosity; Female; Hemostasis; Humans

1987
The consent form as a possible cause of side effects.
    Clinical pharmacology and therapeutics, 1987, Volume: 42, Issue:3

    Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Digestive System; Humans; Informed Consent; Plac

1987
Dissolution of angiographically detected intracoronary thrombus for unstable angina pectoris after aspirin therapy.
    The American journal of cardiology, 1987, Sep-15, Volume: 60, Issue:8

    Topics: Aged; Angina Pectoris; Angina, Unstable; Angiography; Aspirin; Coronary Disease; Coronary Thrombosis

1987
[Effect of hemosorption and the separate and combined use of obsidan, trental and colpharit on rheological and hemostatic properties of the blood in patients with unstable stenocardia].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:5

    Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Aspirin; Blood Viscosity; Combined Modality Therapy;

1986
Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia.
    Journal of the American College of Cardiology, 1985, Volume: 5, Issue:2 Pt 1

    Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Aspirin; Cardiac Pacing, Artificial; Coronary Ci

1985
Anticoagulants: a guide for practitioners.
    Postgraduate medicine, 1973, Volume: 54, Issue:2

    Topics: Angina Pectoris; Anticoagulants; Aspirin; Dicumarol; Disseminated Intravascular Coagulation; Electri

1973
[Differential treatment of coronary heart disease].
    Zeitschrift fur arztliche Fortbildung, 1974, Jul-01, Volume: 68, Issue:13

    Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; H

1974